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ABSTRACT 
A comparative study was made between Manuka honey-the main honey used as an 
antibacterial agent in medicine and some commercially available honeys. Among 22 
types of honey, five types were found to be the most effective and these are Rainforest 
+30, Manuka +20, Nigella sativa, Oak and New Zealand Rewarewa. Three types of 
honey showed negative response to Catalase (an enzyme which breaks hydrogen 
peroxide), namely New Zealand Rewarewa, Manuka +20 and Rainforest +30.  
 Exposure of honey to autoclaving generally leads to a reduction in its antibacterial 
activity. This suggests that hydrogen peroxide and other antibacterial factors are 
removed/denatured by autoclaving, but that in the case of Manuka against S. aureus 
and Rain forest+30 against Ps. aeruginosa, some; unknown, non-destroyed, 
antibacterial factor remains.   
The antibacterial effects of honey on Fusobacterium nucleatum (an anaerobic 
bacterium which is a major cause of mouth abscesses) were studied. Undiluted 
Manuka honey was again shown to be the most effective antibacterial honey against 
this pathogen. Three types of bacteria were isolated from honey as contaminants. 
These were identified using 16SrRNA as: Lysinibacillus fusiformis, Staphylococcus 
epidermidis and Sporosarcina koreensis; and were respectively isolated from Oak 
honey, Nigella sativa honey and Manuka honey. 
Some commercial products containing Manuka honey were tested for their 
antibacterial efficacy. With the exception of the Manuka Honey Conditioner, all of the 
products showed antibacterial activity against S. aureus such as Body wash, 
Shampoo, Manuka oil, Kanuka oil, Manuka Body Wash, bee venom with Manuka 
honey and Vita Complex. Similar results were obtained when Ps. aeruginosa tested. 
However, in all cases, the antibacterial effect on both bacteria was more pronounced 
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against S. aureus than it was against Ps. aeruginosa. The antibacterial effect of the 
three mouth-cleaning products was then tested against some bacterial mouth flora. 
The Manuka and Aquafresh tooth paste showed inhibition zones for all three bacteria, 
while the non-honey mouthwash had no effect on bacterial growth.  
Four types of honey were diluted from 80% to 5% to determine the minimum biofilm 
eradication concentration (MBEC). At a concentration of 20% all honeys killed both 
types of biofilm bacteria. Some pathogenic traits such as pyocyanin production and 
biofilm formation were found to be influenced by a range of honeys. 
Various wound dressings and wound treatments were tested for their antibacterial 
activity against planktonic and biofilm of S. aureus and Ps. aeruginosa. Panaderm, a 
mixture of antibiotics, was the most effective treatment against S. aureus and Ps. 
aeruginosa. Activon Manuka exhibited marked activity against S. aureus and 
moderate activity against Ps. aeruginosa.  Flamazine showed moderate action against 
S. aureus and Ps. aeruginosa. The proprietary (non-honey based) hand gel showed 
weak action on both types of bacteria. 
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General Introduction 
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1 Introduction 
The ability of pathogens (bacteria, fungi, viruses, and parasites) to infect a living host 
is called pathogenicity. Some pathogens possess virulence factors which enable them 
to initiate infection, including the ability to adhere to hosts cell using special structure 
like pilli, secrete toxins and enzymes, and finally, the ability to protect themselves 
from phagocytic cells due to the possession of outer membranes or capsules.  
 
1-1 Some important pathogenic bacteria 
        Although medically important bacteria vary from severe to weak pathogens the 
weaker ones may become more dangerous when they acquire new resistance 
determinants.    
 
1-1-1 Staphylococcus aureus 
The pathogenic bacterium Staphylococcus aureus is a Gram-positive coccus which 
appears as grape-like clusters when viewed through a microscope. The main 
pathological features of S. aureus include the ability to produce the following toxins 
and toxic components: 
1' Catalase (an enzyme which breaks down hydrogen-peroxide to water). 
2' Coagulase (an enzyme which protects it against phagocytes cells by clot 
formation). 
3' Haemolysins (S. aureus secrets a haemolysin which lyses red blood cells, 
including those present on Blood Agar plates). 
4' Protein A (a compound which is found on the cell surface of about 95 % of 
human strains of S. aureus and has the ability to bind the Fc portion of 
3!
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immunoglobulin G (IgG). Protein A gives the bacterial cell antiphagocytic 
trait. 
5' Fibrinolysin which digests fibrin. 
6' Leucocidin which kills leucocytes. 
7' Hyaluronidase gives the bacteria spaces between host cells by breaking 
down hyaluronic acid. 
8' Lipase which digests lipids. 
9' DNAase which hydrolysis DNA. 
10' Epidermolytic toxins A and B are responsible for epidermal splitting and 
exfoliation. 
11' Enterotoxins which causes vomiting and diarrhoea. 
12' Toxic shock syndrome toxin-1, causing shock, rash and desquamation. 
Staphylococcus aureus can be found in wounds, bed sores, and skin infections and 
can cause hospital acquired or community acquired infections. S. aureus is more 
resistant to antibiotics in the hospital environment and can be transformed to the 
problematic methicillin resistant S. aureus (MRSA) form. Generally, MRSA exhibit 
resistance to a number of antibiotics, including  pencillins, cephalosporins, 
chloramphenicol, tetracycline, fluroquinolones and others (Zinner, 2007). 
Vancomycin is now, as the result of necessity, the drug of choice for MRSA 
infections, although since 1997 bacteria have been  developing resistance to this 
antibiotic (Hiramatsu et al., 1997). In addition, many vancomycin resistant S. aureus 
(VRSAs) are being isolated from medical institutions globally (Hiramatsu, 2001, 
Tiwari and Sen, 2006). 
 
 
4!
!
1-1-2 Pseudomonas aeruginosa 
        Pseudomonas aeruginosa is a Gram-negative bacillus which is an opportunistic 
pathogen that affects immune compromised individuals and causes life-threatening 
infections, notably in cystic fibrosis patients and debilitated patients such as those 
with burns or malignancy. In addition, Ps. aeruginosa causes urinary tract infection, 
wound infection, chronic otitis media and lower respiratory tract infection.  
     Pseudomonas aeruginosa has some virulence factors which cannot be ignored 
such as pyocyanin (Molinari et al 1993), and exotoxin A which affect protein 
synthesis in the host cell (Azghani, 1996). Moreover, the bacterium is difficult to 
eradicate and control with antibiotics or disinfectants. 
      The main problem with Pseudomonal infection or colonization is that 
unfortunately, there is only a limited number of antimicrobial agents which possess 
reliable activity against Ps. aeruginosa; these include antipseudomonal penicillins, 
cephalosporins, carbapenems, and fluoroquinolones, particularly ciprofloxacin 
(Carmeli et al., 1999).  
Pseudomonas spp have natural immune characteristics which enable this genus of 
bacteria to grow and survive in the presence of some types of antibiotics than other 
Gram negative bacteria. These characteristics are impermeability and efflux or 
pumping out system which prevent accumulation of antibiotics within the bacterium 
before they have the opportunity to hit the actual target inside the bacterial cell 
(Tenover, 2006). 
 
1-2 Antibiotics site of action 
Antibiotics in general hit four targets inside the microbial cell or interact with the 
function of some other targets (Figure1).  
5!
!
 
Figure 1. Major Targets of Antimicrobial Agents 
(http://amrls.cvm.msu.edu/) 
!
These targets have a unique structure(s) which is different from the host cell and 
which antibiotics can easily recognise (Table1). 
 
Table 1. Sites of action of antibacterial agents (Finch and Garrod, 2003) 
SITE AGENT PRINCIPAL TARGET 
CELL WALL Penicillins transpeptidase Cephalosporins transpeptidase 
Bacitracin isoprenylphosphate Glycopeptides Acyl-D-alanyl-D-alanine 
RIBOSOME Chloramphenicol peptidyl transferase Tetracyclines ribosomal A site 
Quinolones DNA gyrase (a subunit)/ topoisomerase IV 
NUCLEIC 
ACID 
Quinolones DNA gyrase (a subunit)/ topoisomerase IV 
Novobiocin DNA gyrase (b subunit) Rifampicin RNA polymerase 
CELL 
MEMBRANE 
Polymyxins phospholipids Ionophores ion transport 
Polymyxins phospholipids Ionophores ion transport 
FOLATE 
SYNTHESIS 
Sulfonamides pteroate synthetase Diaminopyrimidines dihydrofolate 
reductase 
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1-3 Bacterial resistance to antibiotics 
Three main mechanisms of antibiotic resistance in bacteria have been found. Bacteria 
can a) change the target of the antibiotic chemically by enzyme deactivation or 
destruction, b) they can physically alter the binding site of the antibiotic within the 
bacterial cell and c) prevent an antibiotic from accessing  its target (Mulvey and 
Simor, 2009). Some examples are shown in Table 2. 
 
TABLE 2. Some examples of method of bacterial resistance to some antibiotic. 
(www.textbookofbacteriology.net) 
ANTIBIOTIC METHOD OF RESISTANCE 
Chloramphenicol reduced uptake into cell 
Tetracycline active efflux from the cell 
β-lactams, Erythromycin, 
Lincomycin 
eliminates or reduces binding of antibiotic to cell target 
β-lactams, Aminoglycosides,  
Chloramphenicol 
enzymatic cleavage or modification to inactivate 
antibiotic molecule 
Sulfonamides, Trimethoprim 
-metabolic bypass of inhibited reaction 
- overproduction of antibiotic target (titration) 
 
In addition, some bacteria exhibit unique types of resistance, for example, MRSA has 
the low-affinity penicillin-binding protein (PBP-2a), encoded by mecA gene. The 
catalytic function of PBP-2a is not affected in the presence of modified synthetic 
penicillins (Oxacillin – Methicillin – Cloxacillinetc) (Zinner, 2007). 
7!
!
Resistance to antibiotics can be natural or acquired.  Natural resistance means that the 
bacterium has either inherited this resistant or it possesses a naturally occurring 
structure or system that makes bacteria unaffected by the killing factor. 
    Some antibiotics are effective against Gram-positive but not against Gram negative 
bacteria. The differences relating to some structure such as a capsule or to a non-
specific permeability barrier present in the outer membrane (Mulvey and Simor, 
2009).New determinants or changes in the genetic material which gives the bacteria a 
novel mechanism of resistance are called acquired resistance. 
   Acquired resistance results from a mutation or from the acquisition of a new 
plasmid or transposon formed by conjugation or transduction or transformation. 
   Mutation can occur in every 10-8 to 10-9 colony forming units (CFU) when exposed 
to antibiotics. Escherichia coli for example, has developed resistance to streptomycin 
by mutation (Newcombe and Hawirko, 1949). The new resistance trait is inherited 
directly by all bacteria in the new generation by what is termed vertical gene transfer 
(VGT). 
   The acquisition of antibiotic resistance occurs when a segment of DNA holding a 
resistance trait is acquired by conjugation or transformation or transduction. This 
process is known as horizontal gene transfer (HGT) and here, the genetic material can 
be moved between bacteria from the same species or even between different species 
(Mulvey and Simor, 2009). Direct contact between donor and recipient cells is 
required in conjugation, a process which enables small pieces of DNA called plasmids 
to be  transferred between cells (Mazel and Davies, 1999). Conjugative transfer of the 
genetic determinants has been  observed between different bacterial species and even 
between bacteria and eukaryotic cells such as yeasts (Finch and Garrod, 2003). 
Transformation occurs when the DNA molecule is acquired from the surrounding 
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environment and combined with the bacterial genome of the recipient cell. In some 
types of bacteria transformation occurs readily and without the requirements for any 
special treatments, as happens in Campylobacter jejuni and Campylobacter coli 
(Wang and Taylor, 1990). 
     DNA or genetic material can also be transferred between bacteria by a 
bacteriophage which carries its own genome plus a fragment of DNA which was 
accepted after the bacterial cell was lysed. The bacteriophage then moves to another 
bacterium and the viral genome becomes integrated into the bacterial gene stream, i.e. 
transduction a process known to occur in Staphylococci (Hawkey, 1998). 
1-4 Resistance to antimicrobial agents 
     The phenomenon of antimicrobial action was largely unknown when Pasteur and 
Joubert discovered that one type of bacteria could inhibit the growth of another. 
Heavy metals, dyes, and later the sulfa drugs, were then used in treating some 
infections before the discovery of the antibiotics. These compounds have limitations 
such as toxicity, side effects and more importantly-they do not have a direct inhibitory 
effect on bacterial cells. Selective toxicity, or the ability of a chemical or a drug to kill 
microorganisms without harming the host is an essential property of antibiotics.  
Penicillin was the first antibiotic to be developed, but unfortunately, after a short 
period of the use, bacteria developed resistance to it (it still however, remains an 
important antibiotic). Nowadays, resistance to antimicrobial agents has developed in 
parasites (Talisuna et al., 2004), fungi (Ghannoum and Rice, 1999), viruses (Gammon 
et al 2008), and more commonly amongst bacteria (Falagas et al 2007). Ghannoum 
and Rice (1999) suggest that the development of bacterial resistance to antibiotics has 
become more important because: 
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1- Bacterial infections are responsible for the bulk of community-acquired 
and nosocomial infections. 
2- The large and expanding number of antibacterial classes offers a more 
diverse range of resistance mechanisms to develop. 
3- The ability to move bacterial resistance determinants into standard well-
characterized bacterial strain facilitates the development of molecular 
mechanisms of resistance in bacterial species. 
Bacteria have developed resistance to all of the different classes of antibiotics (Alanis, 
2005). For example, Sieradzki et al. (1999) reported a case of a Vancomycin resistant 
S. aureus, whereas  Vancomycin is the drug of choice in case of Methicillin resistant 
S. aureus (MRSA) (Sieradzki et al 1999); resistance to Imepenem has also been 
shown in some strains of Ps. aeruginosa (Lepelletier et al., 2010, Bahar et al., 2010). 
Bacterial resistance results largely from a) misuse and b) genetic changes occurring in 
the pathogen. Firstly, excessive and often unnecessary use of antibiotics can 
significantly contribute to the emergence of bacterial resistance, as can the lack of 
appropriate implementation of antibiotic policy, lapses in hygiene or poor infection 
control practise (Rao, 1998). Secondly, as we have seen, bacteria have become 
resistant to antimicrobial agents as a result of chromosomal changes or the exchange 
of genetic material via the development of plasmids and transposons. The cost of 
treatment increases following the development of bacterial resistance due to need of 
extra healthcare; in the USA for example,  a single case of Methicillin resistant S. 
aureus can cost more than $60,000 to treat (Anderson et al., 2009), and the estimated 
cost of antibiotic resistance for hospitals is more than $20 billion (Roberts et al., 
2009), In one hospital in Netherlands, the cost of very strict anti-resistance measures 
for a ten year period  has reached 2,800,000 Euros (Vriens et al., 2002).  
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     Increased antibiotic resistance is significantly associated with increased morbidity 
and mortality rates in nosocomial infections (Acar, 1997, Goldmann et al., 1996). 
Carmeli et al (1999) showed that the prolonged hospitalization of patients resulted in 
the acquisition of Ps.aeruginosastrains, which are highly resistant to antibiotics such 
as Ceftazidime, Imepenem, Pipracillin and Ciprofloxacin. 
 
1-5 Biofilms 
Biofilms are microbial communities (bacteria, archaea, protozoa, fungi and algae) 
where cells are enclosed within a slime layer attached to living or non-living surfaces, 
resulting in a small community with an elaborate structure and organization. Biofilms 
originate with the adhesion of a single cell on a surface via physical attraction of the 
microbial cell to a substrate and ends with the formation of a biofilm matrix (Figure 
2). Some chronic bacterial infections are related to the formation of biofilms which 
are inherently resistant to antimicrobial agents (Costerton et al., 1999). Biofilms are 
important in bacterial resistance because the minimum inhibitory concentration to kill 
bacteria within a  biofilm is about 100 to 1000 times greater than that seen for the 
planktonic bacteria (Stewart and Costerton, 2001).  
     Costerton et al (1999) confirmed that this inability of the antimicrobial agent to 
penetrate the depth of the biofilm contributes to biofilm resistance, a result which may 
also be due to starvation (Chambless et al., 2006), since non-growing cells are 
generally not susceptible to antimicrobial agents (Costerton et al., 1999). 
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Figure 2.Formation of a biofilm.(http://eng-cs.syr.edu/our-departments/biomedical-
and-chemical-engineering/research/control-of-bacterial-biofilm-formation) 
 
1-6 The importance of finding alternatives to antibiotics 
        Antibiotic use may bring about the following problems:  
1- Side effects: as chemical products antibiotics produce many undesirable side 
effects thereby requiring physicians to take extra care when prescribing; the 
side effects range from simple to severe. 
2- Contribution to cancer:  Velicar et al (2004) suggested that there is an 
association between the use of antibiotics and breast cancer. 
3- The killing of the normal flora, either inside or outside the body, increases the 
risk to health. For example, Clostridium difficile is inhibited by the normal 
floral barrier in human and animal guts which prevents infection (Borriello, 
1990); the removal of this by antibiotics may allow the pathogen to increase.  
4- The development of  immune suppression, especially following the long term 
use of antibiotics (Van Vlem et al., 1996). 
5- Some factories involved in antibiotics industry discharge their waste directly 
in the environment, thereby causing pollution problems (Homem and Santos, 
2011). 
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There is therefore a critical need to find new compounds to overcome these problems, 
notably in relation to antibacterial resistance.  
 
1-7 Alternative approaches to the use of antibiotics   
In time, antibiotics will be no longer effective on microorganisms due to significant 
increases in resistance and to shortages of new antibiotics. Replacement with natural 
and effective products is therefore extremely important. Alternative medicines might 
be used; these are generally natural products which were mentioned in the history of 
ancient civilisations. These products are as diverse from culture to culture and region 
to region and have been used since antiquity to affect cures. However, the significant 
shift to antibiotics in the 1940s resulted in the neglect of these treatments, examples of 
which include apitherapy (i.e. honey therapy), maggot therapy, algae, and herbal 
therapy. 
 
1-7-1 Apitherapy (Honey therapy) 
Although honey has been used as a food and a medicine since antiquity, it has been 
fully accepted as a therapeutic agent only since 1999. The first two types of honey 
which were used as medicine were the Australian honey, Jelly bush, and the New 
Zealand honey, Manuka. The merits of honey have now been well investigated (Table 
3). 
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Table 3. The merits of honey(Al-Waili et al., 2011) 
Merit Component Function 
Supporting 
the immune 
system 
Antioxidants Such as flavonoids and aromatic acids which reduce 
inflammation and cell damage. 
Unknown 
components  
Natural honey contains raw materials which lower the 
production of prostaglandins which play a role as 
immunosuppressant and a critical role in cancer 
development. 
L-arginine Enhances nitric oxide production which plays role in the 
immune response.  
Killing 
factors 
Hydrogen 
peroxide 
A strong killing factor that is generated by glucose 
oxidase which is added by bees to nectar.  
Methylglyoxal Non-peroxide honey such as Manuka honey contains 
such a unique killing factor. 
Osmolarity High sugar content ties up water molecules so that 
microorganisms have insufficient water to grow. 
Acidity In acidic environment (pH generally between 3.2 and 
4.5) most microorganisms cannot grow. 
Wounds 
healing 
Physical barrier When covering wounds with honey, a thick layer is 
developed which is very difficult to penetrate by 
environmental contaminants; this creates a moist wound 
healing environment. 
Nitric oxide Cell proliferation, wound contraction and collagen 
formation are regulated by the inducible isoform (iNOS) 
of Nitric Oxide which is synthesized in the early phase 
of wound healing by macrophages (Witte and Barbul, 
2002).  
Hydrogen 
peroxide 
Vascular endothelial growth factor (VEGF) is an 
important angiogenic factor for wound healing. H2O2 
induces the VEGF promoter in macrophage through an 
oxidant which results in increasing in VEGF production. 
Nutrients Glucose –Fructose 
– Minerals – 
Vitamins – 
Antioxidants – 
Amino acids 
Honey contains such compounds which may play role in 
its activity and potency 
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1-7-2 Propolis 
Propolis is a product of bees which contains several compounds such as amino acids, 
steroids, inorganic and phenolic compounds (Mundo et al., 2004) which have 
antimicrobial properties against a wide range of microorganisms (Hegazi et al., 2000, 
Serkedjieva et al., 1992, Higashi and de Castro, 1994). 
 
1-7-3 Maggot therapy 
Maggot therapy is an old approach which employs the ability of some flies larvae to 
cause debridement and sloughing of necrotic tissue (Figure 3), as well as the ability to 
produce antibacterial agents. Lucillia sericata is the most common species of blowfly 
maggot used in medicine.  Maggots are particularly  effective in treating indolent 
diabetic wounds (Sherman, 2003). A study has shown that the maggot therapy is more 
effective when used on wounds infected with Gram-positive bacteria such as S. 
aureus rather than ones caused by Gram-negative bacteria (Jaklic et al., 2008). An 
antimicrobial peptide called Lucifencin can be found in haemolymph, fat body and 
excretions/secretions (ES) of the maggot (Andersen et al., 2010, Cerovsky et al., 
2010).  Cazander et al (2009) demonstrated that the excretions/secretions (ES) of 
maggots can reduce biofilm formation by Ps. aeruginosa. 
 
Figure 3. Maggot therapy in action in a wound 
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   Clearly no one would advocate the application of living maggots to infected wounds 
in place of effective antibiotics, even ignoring the relative effectiveness of the two 
approaches a move away from “scientific medicine” to a primitive bio-control 
technique would undoubtedly be seen as an embarrassment by most of the medical 
profession. The return of maggot therapy highlights the desperate state in which 
modern medicine finds itself, a situation which is made embarrassing by the fact that 
it is largely down to its own making due to the mis-prescribing and wasteful way in 
which antibiotic use has been squandered over the last half century and more. Medical 
science has, at least for the moment, had to turn away from highly sophisticated 
approaches to infection control to the use of old fashioned approaches which are 
based on folklore or even old wives tales. Such a picture is however, misleading as all 
of the alternative approaches studied in this thesis are backed up by scientific 
rationales, many of them developed at a time before the introduction of antibiotic 
therapy. The classic example of this is the scientific rationale behind maggot therapy 
which was extensively worked out in the 1930s by Baer, his co-workers and followers 
(Wainwright, 1988). In the same way, all of the necessary methods required to 
successfully apply maggot therapy in medical practice were well-worked out 
before71940, when the method was made redundant. It is interesting to note that 
while maggot therapy was widely used in the USA in pre-antibiotic days, its use was 
never sanctioned in the UK, despite its obvious effectiveness. As a result, while US 
patients who suffered from disgusting, suppurating indolent infections could be 
relieved of their symptoms, those in the UK, who were denied maggot therapy, 
largely on the basis of bigotry, had to continue suffering (Wainwright, 1988).  
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1-7-4 Quorum quenching 
Bacteria have the ability to communicate inside some communities such as biofilms 
using signals i.e. quorum sensing. In order to escape from the immune response of the 
host it is very important for pathogenic bacteria to coordinate their actions.  
Interfering with that communication either by degrading or modifying of the 
signalling molecule affects some pathogenic behaviour such as biofilm formation or 
interferes with virulence factors i.e. quorum quenching or quorum inhibition (Miller 
and Bassler, 2001, Nealson et al., 1970). It has been proved experimentally that some 
natural products block quorum sensing in Ps. aeruginosa such as garlic (Bjarnsholt et 
al., 2005, Bodini et al., 2009), Green tea (Camellia sinesis) (Vattem et al., 2007, 
Bodini et al., 2009), orange extract (Truchado et al., 2012) and  honey (Truchado et 
al., 2009a). 
1-7-5 Herbal therapy 
        The use of a plant or a part of a plant to treat disease is known as herbal therapy 
(Herbalism). Since many drugs have been derived from botanical sources, the medical 
effects of some herbs or herb oils are well known. Table 4.lists some herbs that have 
been found to have activity against microorganisms. 
Table 4. Some examples of herbal medicines 
Common name Scientific name Reference 
Onion Allium cepa Elnima et al (1983) 
Garlic Allium sativum Harris et al (2001) 
Tamarind Tamamrindus indica Kothari and Seshadri (2010) 
Fennel Foeniculum vulgare La Cantore et al (2004) 
Dill Anethum graveolens Kaur and Arorra (2009) 
Green tea Camillia sinensis Gordon and Wareham (2010) 
Black Seeds Nigella sativa Chaieb et al (2011) 
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1-8 Research objectives 
The overall aim of this work is to investigate many types of honey, collected from 
different sources and regions, to determine which are the most active as antibacterial 
agents and which might offer an effective alternative, in the face of increasing 
bacterial resistance, to the antibiotics currently in use.  
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Chapter 2 
Studies on the Antibacterial Activities of a 
Range of Commercially Available Honeys 
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2-1 Introduction 
The curative properties of honey have been known since ancient times, especially as a 
topical agent for use on wounds. The Quran states that the God inspired the bees to 
eat from all fruits so that can make a liquid with different colours and a healing effect 
for people (Chapter fourteen, Surat Al Nahel verse No.69). Honey shows inhibitory 
activity against a wide range of microorganisms (Al-Waili, 2004, Sheikh et al., 1995), 
including bacteria such as Bacillus cereus, Staphylococcus aureus, Salmonella, and 
Shigella dysenteriae (Ceyhan and Ugur, 2001), as well as anaerobic bacteria 
(Elbagoury and Rasmy, 1993). Molan (1999) reported that the use of honey has 
recently become more acceptable to both practitioners and the general public. Honey 
can be used on many types of surface infections  (Lusby et al., 2005) as well as 
internal infections, notably intestinal infections (Adebolu, 2005). 
        Honey is made up of more than 181 components and is a mixture of 
supersaturated sugars mainly fructose (38%) and glucose (31%). The moisture content 
is about 17.7%, total acidity 0.08% and ash content 0.18%. Additional components 
present, at much lower levels, include phenolic acids and flavonoids, enzymes such as  
glucose oxidase and Catalase, ascorbic acid, carotenoids, organic acids, amino acids, 
proteins, and α-tocopherol (Viuda-Martos et al., 2008). 
The diversity of honey depends on the species of bee involved, the botanical source of 
nectar or exudates collected by the bee, climate, geographical region, the harvesting 
process, storage conditions and length of storage. The inhibitory activity of honey is 
not attributable only to the sugar content (Cooper, 2007), however, Mundo et al 
(2004) showed that flavonoids and proteinacious compounds play a role in its 
antimicrobial activity. The acidity of honey (pH generally between 3.2 and 4.5) also 
helps to inhibit microbial growth (Iurlina and Fritz, 2005). Moreover, Bogdanov 
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(1997) suggested that a part of the antimicrobial efficacy of honey might relate to the 
plant origin of nectar. 
        There are broadly two types of honey, namely non-peroxide based and peroxide 
based. The first has the ability to inhibit microorganisms in the presence of Catalase 
(an enzyme which breaks down hydrogen peroxide)  while the second type  lacks this 
ability (Cooper, 2007). Hydrogen peroxide is generated from the oxidation of glucose 
by glucose oxidase (an enzyme secreted by bees as they deposit nectar into the hive 
(White et al., 1963). 
       Non-peroxide honey is more useful in wound treatment than the peroxide-based 
honey which loses its activity in the presence of the Catalase secreted by many types 
of bacteria, notably S. aureus. Manuka honey from New Zealand and Jelly bush 
honey from Australia are two examples of non-peroxide honeys.  Manuka honey is 
unique and heat stable and contains an antibacterial component, which has been 
identified as methylglyoxal (Figure 4)(Adams et al., 2009). 
 
 
Figure 4. Methylglyoxal (Wikipedia) 
 
   Honeys are also effective against biofilms where antibiotic treatment is generally 
less effective; honey having the ability to penetrate and inhibit biofilms formed by    
S. aureus, Methicillin resistant S. aureus, ESBL Klebsiella pneumonia and              
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Ps. aeruginosa (Merckoll et al., 2009). Al Andejani et al., (2009) reported that 
Manuka and Sidr honey have an above average bactericidal rate against previously 
established biofilms of S. aureus, Methicillin resistant S. aureus, and Ps. aeruginosa. 
Recently Cooper et al (2011) showed that Manuka honey can either interfere with 
biofilm formation or can kill members of an already established biofilm. 
The aim of the work reported in this Chapter was to evaluate the effectiveness of 22 
different types of honey on pathogenic bacteria by testing them using a well diffusion 
assay. The most effective honeys were then subjected to the determination of: 
1- Minimum Inhibitory Concentration (MIC). 
2- Minimum Bactericidal Concentration (MBC). 
3- The effect of Catalase treatment. 
4- The effect of exposure to peroxide. 
5- The effectiveness of honey when all enzymes have been deactivated. 
6- The activity of honey on anaerobic bacteria. 
7- The isolation of bacteria and fungi from the most effective antibacterial 
honeys. 
8- The effects of the isolates which have been isolated from honey on the 
pathogenic bacteria.  
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2-2 Material and methods 
2-2-1 Honey samples 
Twenty two honey samples were obtained from various sources. Manuka honey was 
obtained from Holland and Barrett, Sheffield, UK and Nigella sativa honey (Nigella 
sativa seeds with Royal Honey) from a local Arabic shop in Sheffield, UK. Twenty 
commercial honey samples were also tested. The botanical source and origin is listed 
in Table 5. 
Table 5. The botanical source and the country of origin of the used honey 
Honey type Botanical Source The origin 
Country 
Zambezi Flowering tree Zambia 
Balkan Linden Lime Flowers Serbia 
New Zealand 
Rewarewa 
Rewarewa tree New Zealand 
New Zealand 
Rainforest 
Wild herbs, flowers and trees New Zealand 
Himalayan Highlands Forest tree Kashmir 
Balkan Black Locust Pollen grains of genus Robinia pseudacacia 
(family Fabaceae), rose family (Rosaceae), 
cabbage family (Brassicaceae) and bean family 
(Fabaceae) (Natalija Uršulin-Trstenjak et al., 
2013). 
Serbia 
Lavender Lavender UK 
Orange Blossom Orange Blossom Spain 
Thyme Thyme Spain 
Oak Oak Spain 
Chestnut Chestnut Italy 
Nigella sativa seeds 
with Royal honey 
Grounded Nigella sativa with Royal honey UK 
Manuka +20 Manuka (Leptospermum scoparium) New Zealand 
Edel Unknown source  
Rainforest +1 Tineo and Ulmo Chilli 
Rainforest +30 Tineo and Ulmo Chilli 
Bee Bio active wild herbs, flowers and trees UK 
Famous Borage herbs UK 
Wald Bluten *honig Forest flower Germany 
Tannen *honig Tannen tree Germany 
Bluten*honig Wild flower Germany 
Wald *honig Forest tree Germany 
*Honig is German for honey 
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2-2-2 Test organisms 
Two of the most common causing wounds infection bacteria were tested: 
Staphylococcus aureus SH1000 and Pseudomonas aeruginosa PA01. 
2-2-3 Well-diffusion assay 
The bacterial suspension was prepared as described in Appendix (1) and measured in 
spectrophotometer to equal the standard turbidity obtained previously.  
Concentrations of 100%, 80%, 40%, 20% and 10% were prepared by dissolving 
honey with sterile distilled water at 40oC for 30 min for each type of the twenty two 
honey samples used. The technique of well diffusion method is described in Appendix 
(2). 
2-2-4 Minimum Inhibitory Concentrations (MIC) 
        The effective antibacterial honeys as determined by well diffusion test were 
chosen to assess the minimum inhibitory concentration (MIC) and minimum 
bactericidal concentration (MBC) from 80% to 5%.The bacterial suspension was 
prepared by inoculating 10 ml of nutrient broth with bacteria and calibrated to 
equalize to 0.5 McFarland turbidity standards. The mixtures were then incubated at 
60oC for 10 minutes and mixed using a Vortex mixer for 2 minutes, and the tubes 
were incubated in 37oC with shaking at 250 rpm for 24hrs. MICs were defined as the 
lowest concentration of honey, which showed no visible growth.  
2-2-5 Minimum Bactericidal Concentrations (MBC) 
 After determining the MIC, all tubes were inoculated on nutrient agar by taking a 
loopful (approximately 10 µl) of the mixture and incubating in 37oC overnight. The 
lowest concentration, which showed no growth on the agar plate, was defined as the 
minimum bactericidal concentration.  
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2-2-6 Catalase treatment 
The most effective types of honey were tested for Catalase activity, and 
Staphylococcus aureus was chosen for the test. Catalase solution was prepared by 
dissolving 2 mg of Catalase provided by Sigma Aldrich UK in 10 ml of ultrapure 
sterile distilled water. Honey was diluted to 50% with distilled water. Diluted honey 
(1ml) was mixed with 1 ml of bacterial suspension in Catalase solution in sterile Peju 
tube and 1 ml of the same diluted honey was mixed with bacterial suspension without 
Catalase as a control in different Peju tube. All tubes were incubated in 370C with 
shaking for 24hrs. Then all tubes were streaked out on Nutrient agar and checked for 
any growth after 24hrs in 370C (Snow and Manley-Harris, 2004); triplicates were 
used throughout. 
2-2-7 Peroxide Test 
The most effective types of honey were tested for the presence of peroxide after they 
were diluted with sterile distilled water at 50%. Instructions provided by 
QUANTOFIX® Peroxide 25 were applied (Appendix 5). Briefly, a test strip was 
dipped for one second in honey solution and read after 15 seconds. The resultant 
colour was compared with the colour scale on the aluminium container and the result 
was observed and recorded as (Negative or +, ++, +++) depending on colour reaction. 
Distilled water was used as a negative control and hydrogen peroxide solution (9% for 
general antiseptic purposes) was used as a positive control. 
2-2-8 The effect of dilution and autoclaving on antibacterial effect of honey 
      Honeys were diluted and autoclaved by the concentrations of 100%, 80%, 40%, 
20% and 10%. Sterile Muller-Hinton agar (20ml) plates were used. The surface of the 
plates was inoculated with previously calibrated inocula of bacteria and allowed to 
dry before incubation in 37o C for 30 minutes. Five wells of 8.0 mm in diameter were 
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cut from the culture media by using a sterile metal cylinder, and then filled with the 
previous mentioned concentrations. Vancomycin (30µg) was used as a positive 
inhibition control for Staphylococcus aureus and Imipenem (10 µg) for Pseudomonas 
aeruginosa. The plates were incubated at 37oC and checked after 24 hrs for clear, 
circular inhibition zones around the wells. These zones were then measured. The same 
steps were performed for raw honey in order to compare the results. 
2-2-9 Activity of honey on anaerobic bacteria 
Fusobacterium nucleatum, one of the major causes of mouth abscess was tested under 
anaerobic conditions in order to evaluate the potency of honey under such condition. 
The same procedures mentioned in well diffusion assay were set up under anaerobic 
conditions. Anaerobic kit generator and anaerobic indicators supplied by Oxoid® were 
used. Cultures were set up aerobically and anaerobically as controls. 
2-2-10 Isolation of bacteria and fungi from the most active honey 
A number of trials were done to isolate microorganisms from honey. Five types of 
honey, Manuka, Oak, Nigella sativa, New Zealand Rewarewa, Rain forest +30 and 
New Zealand Rainforest were diluted 50% V/W and applied to media supplemented 
with antimicrobial agents as follows: 
 2-2-10-1 Isolation of fungi and yeast 
   Czapek Dox Agar was supplemented with penicillin (5000 units/ml) and 
streptomycin (5 mg/ml) to exclude the growth of Gram positive and Gram negative 
bacteria respectively. 
 2-2-10-2 Isolation of bacteria 
   Nutrient agar was supplemented with Nystatin (1250 units/ml) (typically as the 
concentration used in Thayer Martin media) in order to exclude the growth of fungi. 
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Aspergillus spp and Staphylococcus aureus were used as controls for media. Bacterial 
DNA was purified and identified as described in Appendix (3). 
2-2-11 Testing the honey isolates on the pathogenic bacteria 
Bacteria and fungi obtained from honey were spread on Muller Hinton agar and 
incubated for 24 hrs at 370C. A bacterial suspension was prepared as mentioned in 
Appendix (1). The surface of the plates was inoculated with previously calibrated 
inoculums of the pathogenic bacteria and allowed to dry before incubation in 37o C 
for 30 minutes. Three wells of 8.0 mm in diameter were cut from the culture media of 
the isolated bacteria from honey by using a sterile metal cylinder, each type has three 
cut and then the piece of agar were applied on the plate on which the pathogenic 
bacteria suspension had been spread. Vancomycin (30µg) was used as an inhibition 
control for S. aureus and Imipenem (10 µg) for Ps. aeruginosa. The plates were 
incubated at 37oC and checked after 24 hrs for clear, circular inhibition zones around 
the piece of agar. These zones were then measured. 
2-2-12 Statistical analysis 
All observations were presented as Mean ± SD (Standard Deviation). The data was 
analyzed bySigmaPlot® 12.0. P≤0.05 was considered as the significance level. 
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2-3 Results and Discussion 
2- 3-1 Disc diffusion assay 
Most of the tested honeys exhibited moderate activity against S. aureus and Ps. 
aeruginosa.  Of the 22 types of honey tested five showed marked antibacterial 
activity (Figure 5). The order of antibacterial activity against S. aureus was: Manuka 
+20,Rainforest +30, Oak, New Zealand Rewarewa and Nigella sativa(Table 6), 
while the order for Ps. aeruginosa was Rainforest +30, New Zealand, Rewarewa, 
Nigella sativa, Manuka +20 and Oak (Table 7). The diversity of  antimicrobial 
activity among different types  of honey is attributed to factors such as botanical 
source(which influences its composition), harvesting time, the site of collection, 
processing and storage conditions (Molan and Cooper, 2000). Dixon (2003) claimed 
that microbial resistance to honey has never been reported. Lack of antibacterial 
activity on honeys may however, result from poor storage conditions, where the 
sugars in honey undergo crystallization and the honey tends to lose its antibacterial 
activity; this may explain why, when tested here, Bee Bioactive and Famous Honey 
exhibited no antibacterial activity. 
 
 
Figure 5. Well diffusion assay (showing clear zones around the wells) 
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Table 6. The effect of different concentrations of various honeys against S. aureus 
determined by well agar diffusion. The values are means of replicates (well 8.0 mm) ± 
Standard Deviation. The most effective honeys are highlighted in yellow. 
 Honey concentrations 
Types of Honey 100% 80% 40% 20% 10% 
Zambezi Plains(ZP) 15 ±0 14 ±1.5 8 ±0 8 ±0 8 ±0 
Balkan Linden(BL) 15 ±1.5 10 ±0.5 8 ±0 8 ±0 8 ±0 
New Zealand Rewarewa(NR) 19 ±1 18 ±1 16 ±0.6 8 ±0 8 ±0 
New Zealand Rainforest 
(NRF) 
13 ±0.6 11 ±0.6 8 ±0 8 ±0 8 ±0 
Himalayan Highlands(HH) 12 ±0.6 10 ±0.6 8 ±0 8 ±0 8 ±0 
Balkan Black Locust(BBL) 8 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
Lavender(L) 10 ±1.7 8 ±0 8 ±0 8 ±0 8 ±0 
Orange Blossom(OB) 12 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
Thyme(T) 11 ±0.6 8 ±0 8 ±0 8 ±0 8 ±0 
Oak(OAK) 20 ±1 20 ±1.5 19 ±0 15 ±0.6 9 ±1 
Chestnut(CN) 15 ±1.5 14 ±0.6 8 ±0 8 ±0 8 ±0 
Nigella sativa (NS) 19 ±0.6 18 ±0.6 16 ±1.7 8 ±0 8 ±0 
Manuka +20 33 ±1 33 ±2 25 ±1.5 8 ±0 8 ±0 
Edel 20 ±1.2 18 ±0.6 8 ±0 8 ±0 8 ±0 
Rainforest +10 22 ±0 22 ±0.6 20 ±0.6 8 ±0 8 ±0 
Rainforest +30 27 ±1.5 26 ±1 26 ±1.2 24 ±0.6 22 ±1 
Bee Bioactive  8 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
Famous 8 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
Wald Bluten honig 22 ±0.6 19 ±0.6 8 ±0 8 ±0 8 ±0 
Tanin honig 24 ±0.6 24 ±4 19 ±0.6 8 ±0 8 ±0 
Bluten honig 21 ±1 8 ±0 8 ±0 8 ±0 8 ±0 
Wald honig 22 ±1.2 19 ±0.6 8 ±0 8 ±0 8 ±0 
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Table 7. The effect of different concentrations of honey against Ps. aeruginosa 
determined by well agar diffusion. The values are means of replicates (well 8.0 mm) ± 
Standard Deviation.  The most effective honeys are highlighted in yellow. 
 Honey concentrations 
Types of Honey 100% 80% 40% 20% 10% 
Zambezi Plains(ZP) 13 ±1.2 8 ±0 8 ±0 8 ±0 8 ±0 
Balkan Linden(BL) 10 ±2.3 8 ±0 8 ±0 8 ±0 8 ±0 
New Zealand Rewarewa(NR) 14 ±1 13 ±1.2 8 ±0 8 ±0 8 ±0 
New Zealand Rainforest 
(NRF) 
10 ±1.5 8 ±0 8 ±0 8 ±0 8 ±0 
Himalayan Highlands(HH) 8 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
Balkan Black Locust(BBL) 10 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
Lavender(L) 10 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
Orange Blossom(OB) 10 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
Thyme(T) 11 ±1 8 ±0 8 ±0 8 ±0 8 ±0 
Oak(OAK) 12 ±0.6 10 ±0.6 8 ±0 8 ±0 8 ±0 
Chestnut(CN) 11 ±0.6 9 ±1 8 ±0 8 ±0 8 ±0 
Nigella sativa (NS) 14 ±1 11 ±1.2 8 ±0 8 ±0 8 ±0 
Manuka +20 19 ±1.2 8 ±0 8 ±0 8 ±0 8 ±0 
Edel 8 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
Rainforest +1 20 ±0.6 18 ±0.6 8 ±0 8 ±0 8 ±0 
Rainforest +30 24 ±0.6 23 ±0.6 21 ±1 20 ±0.6 8 ±0 
Bee Bio active  8 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
Famous 8 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
Wald Bluten honig 8 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
Tanin honig 8 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
Bluten honig 8 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
Wald honig 8 ±0 8 ±0 8 ±0 8 ±0 8 ±0 
 
30!
!
2-3-2 Minimum Inhibitory Concentration (MIC), Minimum Bactericidal 
Concentration (MBC) 
Five types of honey: Manuka+20, Nigella sativa, Oak, New Zealand Rewarewa and 
Rainforest +30 were chosen, following recognition of their marked antibacterial 
activities, to determine their minimum inhibitory concentration (MIC) and minimum 
bactericidal concentration (MBC). Figures (5 and 6) show that the minimum 
inhibitory concentration (MIC) was 10% against S. aureus for  Nigella sativa Oak, 
New Zealand Rewarewa and Manuka,  whereas, the minimum bactericidal 
concentration (MBC) for all these honeys was 20% (Figure 6). However, the 
minimum inhibitory concentration (MIC) and minimum bactericidal concentration 
(MBC) of Rainforest +30 against S. aureus was 5%.   
Manuka +20 showed a MIC of 10% against Ps. aeruginosa whereas the MIC was 5% 
for Rainforest honey (Figure 7). Against Ps. aeruginosa, Rainforest +30 was the most 
effective antibacterial honey type, with a MBC of 10%. The following honeys 
exhibited MBCs of 20%; Manuka +20, Nigella sativa, Oak and New Zealand 
Rewarewa. 
 
2-3-3 The antibacterial effectiveness of honey after treating with Catalase 
   In order to determine the degree of involvement of hydrogen peroxide in the 
antibacterial effects of the honeys, samples were diluted in a Catalase solution to 
breakdown (and inactivate) the inherent hydrogen peroxide. Three types of honey 
showed negative response to Catalase, namely New Zealand Rewarewa, Manuka +20 
and Rainforest +30. Whereas, Oak Honey and Nigella sativa honey were completely 
deactivated by Catalase (Table 8). 
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Figure (6): Minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) of different honeys against S. aureus 
 
 
Figure (7): Minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) of different honeys against Pseudomonas aeruginosa. 
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  These results show that the first three-named honeys contain complex antibacterial 
agents, in addition to a small amount hydrogen peroxide; whereas the antibacterial 
activity of Oak Honey and Nigella sativa honey was due only to hydrogen peroxide, 
and that these honeys contained no complex antibacterial agents; similar conclusions 
were arrived by Brudzynski (2006). 
 
Table 8.Catalase effect on honey  
Honey type Control 1 2 3 
Oak _ + + + 
Nigella sativa _ + + + 
New Zealand Rewarewa _ _ _ _ 
Manuka +20 _ _ _ _ 
Rainforest +30 _ _ _ _ 
 
+ = Antibacterial activity lost in presence of Catalase 
_ = No effect of Catalase on antibacterial activity 
 
2-3-4 Determination of the role of peroxide in the antibacterial activity of honeys 
using the peroxidase strip test 
The results given in Table (9) show that only Manuka honey +20,  which is produced 
from the botanical source Leptospermum scoparium was a non-peroxide honey as has 
been reported byAdams et al.,(2009)!andPacker et al., (2012). Whilst, Rainforest +30 
honey shows marked peroxide activity when diluted with water, followed by Oak 
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honey; New Zealand Rewarewa and Nigella sativa honeys showed a low content of 
peroxide. The antibacterial activity of Rainforest +30 honey is clearly due to its 
hydrogen peroxide content although, as mentioned above, in other honeys (like 
Manuka) the antibacterial effect is due not only to hydrogen peroxide, but to more 
complex antibacterial agents which result from the plant-source of the honey, a 
conclusion similarly arrived at by Taormina et al., (2001). 
 
Table9. Hydrogen peroxide content in honey  
Type of Honey  Result Images 
Negative control Negative  
New Zealand 
Rewarewa 
+ 
 
Manuka+20 Negative  
Oak, ++ 
 
Nigella sativa + 
 
Rainforest +30 +++  
Positive control +++ 
 
 
2-3-5 Effect of dilution and autoclaving on antibacterial effect of honey 
Hydrogen peroxide and a number of antibacterial enzymes are liberated from some 
honeys on dilution with water (Bang et al., 2003). The honeys shown in Figure (8 and 
9) were autoclaved for 15 minutes at 100% (raw honeys) and after dilution to 80% 
shows that autoclaving of raw honeys reduced antibacterial activity against S. aureus 
of all of the honeys, but only significantly so in the case of Manuka honey. The same 
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result was seen when the honey were diluted to 80% before autoclaving, showing that 
while dilution is considered to release antibacterial factors there was no difference 
seen here between the use of raw and diluted honeys.   In the case of Ps. aeruginosa, 
autoclaving had no significant effect on the activities of all honeys except for 
Rainforest +30 when used raw or diluted (Figure 10 and 11).  
    The results shown in Figures (8,9, 10 and11) show that autoclaving honey generally 
leads to a reduction in its antibacterial activity against both S. aureus and Ps. 
aeruginosa but this was seen to be significantly different only in the case of Manuka 
honey for S. aureus and Rain Forest honey +30 for Ps. aeruginosa. This suggest that 
hydrogen peroxide and other antibacterial factors are removed/denatured by 
autoclaving, but that in the case of Manuka against S. aureus) and Rain Forest+30 
(Ps. aeruginosa) some, non-autoclaveable, antibacterial factor remains.   
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Figure 8. Activity of raw and autoclaved honey against 
S. aureus at 100% (*Significant difference at 0.05) 
 Raw Honey  
 Autoclaved Honey 
 
RNS= Raw Nigella sativa honey  
ANS= Autoclaved Nigella sativa honey 
RRF= Raw Rainforest honey 
ARF= Autoclaved Rainforest honey 
RM= Raw Manuka +20 honey 
AM=Autoclaved Manuka +20 honey                                                                                       
RO= Raw Oak honey                                                                                                           
AO= Autoclaved Oak honey                                                                                                    
RNR= Raw New Zealand Rewarewa honey                                                                       
ANR= Autoclaved New Zealand Rewarewa honey 
*"
36!
!
Honey samples
RNS ANS RRF ARF RM AM RO AO RNR ANR
 Zo
ne
 d
ia
m
et
er
 (m
m
)
0
5
10
15
20
25
30
Figure 9. Activity of raw and autoclaved honey against 
S. aureus at 80% (*Significant difference at 0.05) 
 Raw Honey  
 Autoclaved Honey 
 
RNS= Raw Nigella sativa honey  
ANS= Autoclaved Nigella sativa honey 
RRF= Raw Rainforest honey 
ARF= Autoclaved Rainforest honey 
RM= Raw Manuka +20 honey 
AM=Autoclaved Manuka +20 honey                                                                                       
RO= Raw Oak honey                                                                                                           
AO= Autoclaved Oak honey                                                                                                    
RNR= Raw New Zealand Rewarewa honey                                                                       
ANR= Autoclaved New Zealand Rewarewa honey 
    * 
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Figure 10. Activity of raw and autoclaved honey against 
Pseudomonas aeruginosa at 100% (*Significant difference at 0.05) 
 Raw Honey  
 Autoclaved Honey 
 
RNS= Raw Nigella sativa honey  
ANS= Autoclaved Nigella sativa honey 
RRF= Raw Rainforest honey 
ARF= Autoclaved Rainforest honey 
RM= Raw Manuka +20 honey 
AM=Autoclaved Manuka +20 honey                                                                                       
RO= Raw Oak honey                                                                                                           
AO= Autoclaved Oak honey                                                                                                    
RNR= Raw New Zealand Rewarewa honey                                                                       
ANR= Autoclaved New Zealand Rewarewa honey 
   * 
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Figure 11.  Activity of raw and autoclaved honey against 
Pseudomonas aeruginosa at 80% (*Significant difference at 0.05) 
 Raw Honey  
 Autoclaved Honey 
 
RNS= Raw Nigella sativa honey  
ANS= Autoclaved Nigella sativa honey 
RRF= Raw Rainforest honey 
ARF= Autoclaved Rainforest honey 
RM= Raw Manuka +20 honey 
AM=Autoclaved Manuka +20 honey                                                                                       
RO= Raw Oak honey                                                                                                           
AO= Autoclaved Oak honey                                                                                                    
RNR= Raw New Zealand Rewarewa honey                                                                       
ANR= Autoclaved New Zealand Rewarewa honey 
   * 
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2-3-6 Effect of honeys on anaerobic bacteria 
Fusobacterium nucleatum is a major cause of mouth abscess. In this experiment the 
antibacterial effects of honeys against this bacterium was tested under anaerobic 
conditions, in order to simulate the anaerobic wound environment. Undiluted Manuka 
honey was again shown to be the most effective antibacterial honey under these 
conditions. However, Oak, Nigella sativa and New Zealand Rewarewa were more 
effective than Manuka when diluted to 40% and 20% (Table 10). The results show 
that certain honeys (again notably Manuka honey) are effective in killing potentially 
pathogenic, anaerobic bacteria; this is obviously an important factor in the treatment 
of wounds, many of which become anaerobic. 
 
Table 10. The effect of different types of honey on Fusobacterium nucleatum when 
grown under anaerobic conditions. The values are means of replicates (well 8.0 mm) 
± Standard Deviation. 
 
 
 
 Zone Diameter(mm) 
Honey Types 100% 80% 40% 20% 10% 
Manuka +20 28±1.2 18±0.58 12±0.58 8 8 
Oak 19±0.58 18±1 18±1.2 13±1 8 
Nigella Sativa 16±1.5 16±1.2 13±1.2 13±0.58 8 
New Zealand Rewarewa 20±2.1 18±1.5 14±0.58 11±1 8 
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2-3-7 Isolation of microorganisms from honey 
During the current studies on honeys it became obvious that some varieties are 
variously contaminated with both bacteria and fungi. The aim of the work reported 
here was to isolate any bacteria from honey and identify those using molecular 
techniques. It is obviously important to determine whether honeys contain 
contaminating microbes, and in particular to determine if such contaminants are 
potential pathogens. Similar studies have been reported by Lee et al., (2008).  Three 
types of bacteria were isolated as honey contaminants, these were identified using 
16SrRNA (Figure 12 and 13) and found to be: Lysinibacillus fusiformis, 
Staphylococcus epidermidis and Sporosarcina koreensis (see Appendix isolates 1, 2 
and 3). They were respectively isolated from Oak honey, Nigella sativa honey and 
Manuka honey. 
 
Figure12. Agarose gel electrophoresis showing a successful DNA extraction from 
unknown isolated bacteria from honey. Lane L, Ladder. 1, 2 are bacterial DNA 
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Figure13. Agarose gel electrophoresis showing a successful amplification of 16S rRNA 
from unknown isolated bacteria from honey. Lane L, Ladder. 1, 2 and 3 are Lysinibacillus 
fusiformis, Staphylococcus epidermidis and Sporosarcina koreensis respectively 
 
Lysinibacillus fusiformis is a gram-positive rod,! none-motile, with an 
approximate length of 2.5-3.0 micrometers and an approximate width of 0.5-
0.9 micrometers. Under adverse conditions, it can generate 
inactive spherical endospores that are resistant to high temperatures, chemical 
sterilizing agents damaging chemicals, and ultraviolet light. The developing 
endospores localize either centrally or terminally within the enlarged sporangia and 
can remain viable for considerable periods. In terms of pathogenicity, L. fusiformis is 
thought to cause tropical ulcers and dermal and/or respiratory infections! .L. 
fusiformis tests positive for oxidase and is an obligate aerobe. Sporosarcina  as the 
name suggests, occurs in packages of cells and forms spores. Many species grow at 
temperatures below 10°C, and are halotolerant and grow in  media containing NaCl at 
a concentration of 3-15%.  
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Some Staphylococci species, such as S. epidermidis is considered as a normal skin 
flora and it has no risk on healthy people. However, most infections of S.epidermidis 
is associated with immuno-compromised patients. 
 
2-3-8 Effect of isolated microorganisms on pathogenic bacteria  
All of the three isolated bacteria referred to above were tested to determine if they 
exhibit any antibacterial activity against S. aureus. None of the isolates showed any 
anti-Staphylococcal activity (Figure 14, 15 and 16). 
 
Figure (14): The effect of Staphylococcus epidermidis isolated from Nigella sativa 
honey on S. aureus (Vancomycin disc used as a positive control) 
 
 
Figure (15): The effect of Lysinibacillus fusiformis isolated from Oak honey on         
S. aureus (Vancomycin disc used as a positive control) 
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Figure (16): The effect of Sporosarcina koreensis isolated from Manuka +20 
honey on S. aureus (Vancomycin disc used as a positive control) 
 
The antibacterial activity of honey has been reported to vary as much as 100-fold 
(Molan, 2001). A finding which agrees with the results given in this Chapter where 
the antibacterial activity of honeys, from around the world, were tested and found to 
be highly variable. Not all honeys can therefore be used for therapeutic purposes, and 
care must be taken before a honey is chosen as a wound dressing; such honeys should 
have a) a high potency level b) a wide spectrum of antibacterial activity, particularly 
against bacteria commonly associated with wound infections (including anaerobes), c) 
marked non-peroxide activity. Non-peroxide antibacterial activity being because 
wound exudates may contain Catalase, which reduces the peroxide-related 
antibacterial activity when applied to the wound surface; any non-peroxide activity 
would, in contrast, be still active. Again, the results presented here confirm the 
marked antibacterial activity of Manuka honey, although the results also show that a 
small number of other honeys can surpass Manuka in antibacterial activity. Results 
presented in this Chapter also show that the antibacterial activity of Manuka honey 
depends on a number of components, notably complex, non-peroxide compounds. 
Manuka (Leptospermum scoparium) honey has been advocated, and found to be 
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effective, for use in wound treatment in the main for this reason (Molan, 2004; Molan, 
2006). Searches for honeys possessing exceptionally high non-peroxide antibacterial 
activity has been a major aim of a number of a number of studies, including the 
present one. For example, in a large survey or 345 New Zealand honeys, Allen et al., 
(1991) showed that only 25 samples of Manuka and vipers bugloss honeys gave a 
significant non-peroxide antimicrobial activity. In another study of Portuguese honeys 
it was found that only 23% showed measurable non-peroxide activity (Henriques et 
al., 2005). Basson and Grobler (2008) showed that not all Manuka honey samples 
show exceptionally high antibacterial activity and associated marked non-peroxide 
activity. The most active Manuka honey appears to be produced from the East Cape 
region of the North Island of New Zealand (Basson and Grobler, 2008). 
   As honey dressings, used in wound management, are changed three times daily 
(Willix et al., 1992), an incubation period of 8 h is generally chosen to evaluate the 
bactericidal concentration of Manuka honey against the most dangerous antibiotic-
resistant pathogen, namely MRSA. Molan (1992b) showed that Gram-positive 
bacteria start to die after 1 hour of honey exposure (Molan, 1992b), so that pathogen-
destruction should occur in the usual dressing-exposure period.  
   The innate properties of honey which include low pH and high sugar content are 
considered to provide harsh conditions which bacteria cannot tolerate and which 
induce starvation-based activities, such as sporulation (Snowdon and Cliver 1996), an 
event known to be associated with degradative enzyme production (Marahier et al., 
1993). An antibacterial compound called, bee defensin-1 has also recently been 
discovered in a medical grade honey (Sherlock et al., 2010). 
The potential presence of Clostridium botulinum spores in honey presents an obvious 
problem (Molan and Allen, 1996), because it is obviously associated with the risk of 
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wound infection. Vardi et al., (1998) however, considered this to be a very low risk 
problem since they could not find a single report of C. botulinum wound infection 
being associated with honey dressings. Simon et al.,(2009) similarly could not detect 
a single case report linking the use of unsterilized honey in wound care and wound 
infections caused by C. botulinum. Local unsterilized honey has also been widely 
used to treat infected wounds and burns without the appearance of C. botulinum 
wound infections (Postmes et al., 1996; Postmes, 2001).  
   In conclusion, the results presented in this Chapter confirm the antibacterial effects 
of honey, (notably Manuka varieties) and suggest that further studies of honeys from 
around the world are likely to lead to the recognition of active honeys which may 
surpass Manuka in their wound-healing potential. 
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Chapter 3 
Antibacterial Activity of Some Commercial 
Products Containing Manuka Honey 
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3-1 Introduction 
The emergence of multi resistant strains of bacteria to commonly used antibiotics has 
necessitated the search for new approaches. Honey, or apitherapy, is one such 
approach. Some other approaches are shown in Table 11.  
 
Table 11. The efficacy of some products when combined with honey 
Type of Honey  Combined 
with 
Acted On Reference 
Sumra (Acacai 
tortilis) 
Propolis S. aureus, E. coli and 
Candida albicans 
(Al-Waili et al., 2012) 
Monofloral honey Essential oils Ps. aeruginosa (Abdellah et al., 2013) 
Tazma  Garlic S. aureus, Streptococcus 
pneumoniaea, 
Lysteria monocytogenes, 
And Salmonella spp. 
 
(Andualem, 2013) 
West Algerian 
honey 
Nigella sativa 
seeds 
Ps. aeruginosa (Abdelmalek et al., 2012) 
Monofloral  Thymes  S. aureus, E. coli and Ps. 
aeruginosa 
(Abdellah et al., 2012) 
Medihoney Rifampicin MRSA and S. aureus (Muller et al., 2013) 
 
3-1-1 Bee venom 
Bee venom is used to relieve pain and treat inflammatory diseases, such as 
rheumatoid arthritis(Kwon et al., 2001) and for the psycho- neurological treatment of 
autoimmune and nervous system disease  (Somerfield et al., 1984, Kwon et al., 2001). 
As well as having an anti-inflammatory effect, bee venom exhibits antimicrobial 
activity against bacteria which cause inflammation such as Propionibacterium acnes, 
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Staphylococcus epidermidis and Streptococcus pyogenes (Han et al., 2010); bee 
venom appears to be more active against Gram positive than Gram negative bacteria 
(Perumal Samy et al., 2007).The most active component in bee venom against 
microorganisms is a compound called melittin (Fennell et al., 1968). 
3-1-2 Manuka oil 
Manuka oil is extracted from the Manuka plant or Leptospermum scoparium which 
occurs in New Zealand. Manuka oil has known antimicrobial properties (Maddocks-
Jennings et al., 2005). The antimicrobial activity of Manuka oil is attributed to  
β-triketones, such as leptospermone, flavesone and isoleptospermone (Christoph et 
al., 2000). 
3-1-3 Kanuka oil 
Kanuka oil is derived from the kanuka plant, Kunzea ericoides. Kanuka oil has 
antimicrobial activity related to the presence of the same components as Manuka 
oil(Maddocks-Jennings et al., 2005). 
The aim of the work described in this Chapter was to test some synthetic and natural 
products combined with Manuka honey including: 
1- Cosmetic products containing Manuka honey: (These are proprietary products 
obtained from Holland and Barrett) 
a. Foaming cleaner. 
b. Foot-Heal cream. 
c. Facial cleaner tonic. 
d. Foaming cream. 
e. Blemish. 
2- Washing products containing Manuka honey: 
a. Body wash. 
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b. Shampoo. 
c. Conditioner. 
3- A complex of bee venom and Manuka honey. 
4- Vita complex (a mix of pollen, royal jelly, honey and propolis). 
5- Manuka oil. 
6- Kanuka oil. 
7- Tooth Paste with Manuka honey compared with conventional toothpaste and 
mouth wash. 
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3-2 Materials and Methods 
Staphylococcus aureus SH1000 and Pseudomonas aeruginosaPA01 were tested; the 
bacterial inocula were prepared as described in the Appendix 1. Tests were applied 
according to physical proprieties of the treatment, for example, well diffusion 
technique (Appendix 2) was used with liquid materials where, with the solid materials 
the treatment was added to the surface of the media and left for 15 minutes followed 
by streaking the bacteria out in parallel lines. For the tooth paste experiment, a sterile 
cotton swab was rubbed in the early morning before mouth washing and cultured on 
Nutrient Agar supplemented with 5% Horse blood (Obtained from Sigma- Aldrich®) 
to isolate the normal mouth flora. Plates were incubated overnight at 370C.  After the 
growth, 16S r RNA techniques were used as described in Appendix 3 to identify the 
isolated bacteria. 
 
3-3 Results and discussion 
3-3-1 The antibacterial activity of some natural and commercial products and 
honey products containing Manuka honey 
None of the Manuka-containing cosmetics had any effect on the growth of Ps. 
aeruginosa (Table 12). In contrast, the effect of the cosmetics on S. aureus was more 
variable, with the foot-heal cream, facial cleaner and foaming tonic having an 
inhibitory effect on growth, while the foot-heal cream and blemish cream showed no 
effect.  
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Table 12.  Effect of various Manuka-containing cosmetics on positive/negative 
growth of bacteria 
Type of cosmetic product Results  
Staphylococcus 
aureus SH1000 
Pseudomonas aeruginosa 
PA01 
Foaming cleaner Positive Negative  
Foot-heal cream Negative Negative 
Facial cleaner tonic Positive Negative 
Foaming cream Positive Negative 
Blemish cream Negative Negative 
 
Positive= No growth after 24 hours of the incubation at 37oC. 
Negative= Bacterium has grown after 24 hours of the incubation at 37oC. 
 
Table 13. shows the effect of a range of honey products on the growth of S. aureus. 
With the exception of the Manuka Honey Conditioner, all of the products showed 
antibacterial activity against S. aureus. The two oils proved markedly antibacterial, 
but perhaps surprisingly the Manuka Body Wash was the most active against this 
bacterium; the bee venom and Vita Complex were also active against S. aureus. 
Again, with the exception of the Manuka Honey Conditioner, all of the products 
showed antibacterial activity against Ps. aeruginosa and again, in all cases, the 
antibacterial effect on both bacteria was more pronounced against S. aureus than it 
was against Ps. aeruginosa. 
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Table 13. The effect of different types of honey and natural products on 
Staphylococcus aureus and Pseudomonas aeruginosa. The values are means of 
replicates (well 8.0 mm) ± Standard Deviation. 
 
3-3-2 Antibacterial activity of mouth cleansing products on mouth flora 
Three types of bacteria were isolated from the mouth, namely Streptococcus mitis, 
Streptococcus gordonii and Neisseria mucosa (see Appendix isolates 4, 5 and 6). This 
isolation compares with the more commonly isolated species, such as Lactobacillus, 
from the mouth.   The antibacterial effect of the three mouth-cleaning products was 
then tested using the well-plate method. The Manuka and Aquafresh tooth paste 
showed reduced inhibition zones of all three bacteria, while the non-honey 
mouthwash had no effect on bacterial growth; the mouthwash was then exempted 
from further study.  
 Zone Diameter(mm) 
Category Material S. aureus Pseudomonas  
aeruginosa 
Washing products 
with 
Manuka Honey 
Body wash. 24.3±1.2 15.7±10.6 
Shampoo. 18±2 14.7±0.6 
Conditioner. 8 8 
 Complex of bee venom and 
Manuka honey 
13.8±0.6 11.7±0.6 
 Vita complex (pollen, royal 
jelly, honey and Propolis) 
13.7±0.6 10±0+ 
Essential oils Manuka oil. 19.3±0.6 10.3±0.6 
Kanuka oil. 16±1 14.7±1.15 
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   Figure (17) shows that both types of toothpaste were effective at killing all of the 
bacteria studied. The Manuka honey toothpaste was particularly effective against    St. 
mitis and St. gordonii while being less effective against N. mucosa than Aqua Fresh. 
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Figure17. The effect of two different toothpastes on mouth normal flora 
 Toothpaste with Manuka honey 
 Aqua Fresh 
 
The following comments relating to the marketing of honey products was largely 
obtained in discussion with Mrs Gloria Havenhand and local honey producer and 
published expert on the lore associated with honey production and sale. Honey is 
produced throughout the world and consumed in various floral types by consumers 
who are seeking choice in flavours texture and claimed health benefits; it can 
therefore be regarded as a so-called “functional food”. Honeys, like many food 
products are exposed to “aspirational selling”, i.e. the sale of a commodity for which 
no specific claims are made, but which are purchased in the belief that they will 
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confer some, unspecified improvement in well-being. Since honeys are relatively easy 
to produce (except where viral and other diseases reduce yields) they are a generally a 
relatively low cost (Manuka honeys provide an exception in that jars can cost between 
40-50 pounds, compared with 3-6 pounds for jars of non-Manuka honey) product 
which is open to competition from cheap supplies from countries where, because of 
climate and other economic factors, production costs are very low. As a result honey, 
producers are always keen to “add value” to their products in order to increase their 
sales and profit margins. This can be achieved by artful labelling which suggest the 
countryside, nature, or emotive historical links with the past (such as references to 
Monks and Abbeys or quaint sounding village names). The use of locality or 
environment can be another useful approach (such as labelling Yorkshire Honey, 
Sheffield Honey, Exmoor Honey) or by specifying the presence of specific floral 
origins, such as Manuka, Wild Blossom, Orange Blossom). An example of the 
success of such an approach can be seen regarding the sale of Medibee honeys the 
retail price (and sales) of which was increased following by labelling referring to the 
established antibacterial properties of these products. Clearly consumers are attracted 
by any added claims, which can be ascribed to the honeys themselves or related 
products. 
   A wide range of health benefits have been claimed for honey in addition to wound 
healing properties. Clearly, few consumers buy Manuka and other “antibacterial 
honeys for use as a wound curative or dressing, as wound health is more likely 
covered by a GP, hospital or nursing home. Consumers are however attracted by other 
claims such as the ability of honey to improve general health, reduce the symptoms of 
arthritis, improving arthritis or hay fever and sinus- related problems. Local honey 
producers often have experience of customers making their own claims for their 
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products which they pass on to other by word of mouth or written or internet 
recommendations. Such endorsements are advantageous to producers as they 
advertise the product without the need for the use of specific health claims to be 
made; they also lead to profitable return visits and spread the product names far and 
wide (Internet sales of honey have as a result grown exponentially over recent years). 
Such medical claims have, in some cases, been backed up by scientific research, while 
in other cases they remain apocryphal. In the past UK regulatory authorities have 
allowed vague statements to be put on honey products along the lines of “antibacterial 
honey, “improves health” etc. Until recently honey producers could make claims to 
antibacterial activity if these claims were backed up by research data(as was the case 
with work from this laboratory which validated antibacterial Medibee honeys)but the 
most recent regulations have prohibited even relatively mild claims from being made 
on packaging concerning the antibacterial properties, real or imagined of honeys.  
    One of the major ways by which honey producers can improve their profit base is 
to add honey to other products thereby producing “added value”. This approach is 
particularly effective in relation to the development of cosmetics like skin care 
products. Such products attract a high premium by making generalized claims, which 
attract customers to buy honey-based cosmetics. For example, a range of Manuka 
based skin care products produced by the New Zealand company Madeleine Ritchie 
claim that honey's natural antioxidant and anti-microbial properties and its ability to 
absorb and retain moisture enable it to be used extensively in skin care treatments in 
order to help protect the skin from the damage of the sun's rays and rejuvenate 
depleted skin. They claim the treatment give the skin a very 'clean' sensation to the 
touch, leaving it feeling non-greasy, elasticated, rejuvenated and hydrated. They 
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further claim that because of its superior antibacterial protective properties, Manuka 
honey is “a luxurious and prized ingredient in any skin care preparation”. 
 An examples of the way in which honey products are marketed is given by the 
following industry statement relating to the bee product-propolis: 
“Propolis is a mainly resinous substance that bees collect from trees and plants. 
Being made up of waxes, resins, fatty acids and even amino acids. Aristotle reputedly 
coined the name Propolis meaning "defender of the city". This is exactly what 
Propolis is for the hive; it acts as a bee population’s external immune system keeping 
the hive sterile and free of microbial invaders. New Zealand propolis is well 
renowned for its natural purity and high levels of antioxidants. We sell propolis in 
two forms - capsules and throat spray providing a convenient way to take advantage 
of the health benefits that propolis can offer. Our propolis capsules are manufactured 
according to the highest Good Manufacturing Practice (GMP) standards”. 
A close examination of this paragraph shows that it links propolis with a long history 
of use it then unspecifically mentions the immune system, health benefits, 
antioxidants and purity of manufacture. Mention of amino acids is given to 
presumably add a scientific veneer to the quote. All of the words are suggestive of 
health benefits, rather than direct medical claims. They leave the purchaser to link all 
the words in their own mind and come to the conclusion that propolis, when added to 
cosmetics, will be beneficial to health.   
Amazingly, in the UK alone each year, honey pots are filled with 1800 tons of 
Manuka and another 10 thousand tons are sold worldwide”. However, the British 
Food Safety Agency (FSA) has issued an international warning about false and illegal 
claims on the labels of Manuka honey and has showed that more than 50 percent of 
the products with that label contain little if any active substances of this esteemed 
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New Zealand Manuka bush tree (Leptospermum scoparium). Additional testing in 
Hong Kong revealed that 14 of the 55 samples of Manuka honey tested as fake. 
Although there are counterfeiters and other countries, it turns out that most companies 
that sell wrongly labelled Manuka honey on the British market comes from New 
Zealand, so that New Zealand primary producers of bee products face greater 
scrutiny, not only in the Europe, but also elsewhere.  
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Chapter 4 
Comparative Effects of Honey and Antibiotics 
on Established Bacterial Biofilms 
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4-1 Introduction 
Bacterial cells can aggregate in biofilms in an elaborate structure enclosed within a 
self-produced extracellular polymeric matrix, i.e. a biofilm (Costerton et al., 1999). In 
general, bacterial biofilms are formed on wet surfaces and mostly can be seen with the 
naked eye. Biofilms are present as an individual bacterium or in a combination of 
different species. The biofilm is highly organised and contain channels allowing the 
distribution of nutrients (Lawrence et al., 1991). Many cases of treatment failure with 
antibiotics are attributed to bacterial biofilms which are not easily eradicated by 
conventional therapy (Tart and Wozniak, 2008). 
   Biofilms present advantages as well as disadvantages. Some biofilms prevent tissue 
colonization by exogenous pathogens, an ability attributed to the production of 
hydrogen peroxide, biosurfactants and acids (Kolenbrander, 2000). Some diseases 
such as gingivitis, peritonitis and caries occur because of the proliferation of biofilms 
(Kolenbrander, 2000),as some implantable medical devices and impairments to the 
immune system lead to the formation of biofilm-related infections (Lindsay and von 
Holy, 2006, Ramsey and Whiteley, 2009). 
 
4-1-1 The mechanism of biofilm formation 
Surface conditioning is the first step in biofilm formation, where surfaces are covered 
with nutrients such as actin, mucin (a glycoprotein) and DNA (Donlan, 2002). The 
second step is bacterial attachment, where cells adhere reversibly to surfaces by 
sedimentation, active movement by motile bacteria and by electrostatic interactions 
(Costerton et al., 1978). Cell-bridges are formed by the production of 
exopolysaccharides, which cement the cells to the surface. An example of an 
exopolysaccharide is alginate, a polysaccharide produced during the formation of Ps. 
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aeruginosa biofilm (Davies and Geesey, 1995, Davies et al.,1993, Stapper et al., 
2004). 
     The final stage in biofilm establishment is surface colonization. The attached 
bacteria proliferate and form micro colonies, which comprise the basic unit of the 
biofilm community (Figure 18).  A wide range of bacterial species can be involved in 
an individual biofilm and some species have the ability to produce proteins, which 
inhibit the attachment of other species. Some peripheral cells can be detached from 
the biofilm thereby returning to the planktonic state to seek a new surface and start a 
new community (Costerton et al., 1999, Davey and O'Toole G, 2000). In Ps. 
aeruginosa biofilms, the enzyme responsible for this process is alginate lyase which 
dissolves alginate to release bacterial cells (Davies et al., 1993). Other mechanisms 
involved in dispersion are alternation of various biofilm surface components (Neu, 
1996) and quorum sensing (cell to cell signalling) which facilitate the release of 
surface-bound bacterial cells (Fux et al., 2005, Davies et al., 1998). 
 
Figure 18. Biofilm formation in Pseudomonas aeruginosa (obtained from 
microbewiki.kenyon.edu) 
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4-1-2 Antibiotic resistance in bacterial biofilms 
Biofilm-related infection symptoms are not readily observed because biofilm growth 
is normally slow, thereby making it difficult to diagnose such any related infections 
(Chambless et al., 2006). Both antibiotics and host defence mechanisms are effective 
on planktonic cells but generally not against biofilms (Leid et al., 2002).The 
concentration of antibiotic needed to kill cells within a biofilm is generally about 100 
to 1000 times greater than that concentration needed to kill the same bacteria in the 
free swimming form (Costerton et al., 1999). 
The resistance of biofilms to antimicrobial agents is attributed to several factors. One 
proposed factor is that the depth of the structure is impenetrable (Costerton et al., 
1999, Jefferson et al., 2005). Cerca (2005) suggested that polymeric substance in the 
biofilm matrix impede diffusion of some antibiotics. Another factor which might 
explain reduced biofilm susceptibility to antimicrobial agent is based on the fact that 
cells in biofilms are slow-growing bacteria or inert and many antibiotics only affect 
actively growing cells (Chambless et al., 2006, Costerton et al., 1999). 
 
4-1-3 Honey and biofilms 
Honey has many therapeutic benefits especially in relation to wounds and it is known 
to inhibit biofilm formation and kill biofilm bacteria (van der Weyden, 2005, Gethin 
and Cowman, 2009). Honey acts as a broad spectrum antimicrobial agent and is active 
against multi drug-resistant bacteria (Chambers, 2006); it is also welcomed by 
patients because it helps reduce both pain and malodour (Dunford and Hanano, 2004). 
Many other biofilms inhibitors also exist, notably  chlorohexidene, garlic, cadexomer, 
iodine, hydrogen peroxide, lactoferrin, polyhexnide, ocetendine, povidone xylitol and 
silver  (Cooper, 2010). Most types of honey have killing activity which is attributable 
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to factors such as acidity, osmolarity and the production of hydrogen peroxide. 
However, some types of honey also contain a unique killing factor called 
methylglyoxal which is particularly prevalent in Manuka honey. Methylglyoxal 
(MGO) shows remarkable action in vitro when tested against biofilms of methicillin 
resistant S. aureus (MRSA) and Ps. aeruginosa; it is also effective against planktonic 
cells (Kilty et al., 2011). Sidr honey from Yemen also has marked biofilm-killing 
activity when tested against methicillin sensitive S. aureus (MSSA), methicillin 
resistant S. aureus (MRSA); the killing factor present in Sidr honey has not however, 
yet to be identified (Alandejani et al., 2009).  
The overall aim of the work reported in this Chapter was to study the effect of honey 
on already established biofilms of S. aureus and Ps. aeruginosa at different 
concentrations and to compare their effects with antibiotics. 
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4-2 Material and Methods 
The Minimum Biofilm Eradication Concentration (MBEC) of two types of the most 
common causing wounds infection bacteria: Staphylococcus aureusSH1000 and 
Pseudomonas aeruginosaPA01was detected according to instructions provided by 
Innovotech Inc. Canada (Appendix3).  
 
4-2-1 Honey treatment 
    Concentrations from 80% to 5% of the effective honeys were prepared in sterile 
tubes and then transferred to wells. The vertical well line was used for one type of 
honey from the third row to the eleventh row. The test for each type of honey was 
done in duplicate. The twelfth row was used as positive control.  
 
4-2-2 Antibiotic treatment 
Two antibiotics were used (Ciprofloxacin for Ps. aeruginosa and Erythromycin for S. 
aureus); concentrations were prepared as stated below in sterile tubes and then 
transferred to wells. Nine serial concentrations of Ciprofloxacin were prepared, 
started with 40mg/ml and ended with 156µg/ml, and Erythromycin was diluted from 
10mg/ml to 39µg/ml. A plate used for an antibiotic and the test was performed in four 
rows. The first and the second rows used as negative control. The twelfth row used as 
positive control.  
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4-3 Results and Discussion 
4-3-1 Effect of honey on biofilm  
Four types of honey were diluted from 80% to 5% to determine the minimum biofilm 
eradication concentration (MBEC). Table 14 shows that at a concentration of 20% all 
honeys killed both biofilm bacteria. The results of this experiment are potentially 
influenced by the fact that a single cell might survive treatment and grow to give 
positive result. In studies used by other workers, another protocol was used which 
depends on the immersion of honey with different concentrations on established 
biofilm in 96 wells plate and assessing the remaining biofilm residues in the plate 
(Cooper, 2011). This protocol was not used in the work reported here because of 
eliminating honey at higher concentration by washing with sterile, distilled water. 
Surprisingly, Cooperet al., (2011) reported that when using this approach Manuka 
killed a S. aureus biofilm at a concentration of 10%. 
 
Table 14.The minimum biofilm eradication concentration (MBEC) of different types 
of honey for S. aureus and Ps. aeruginosa biofilms. 
 
 
Minimum biofilm eradication concentration 
(mg/ml) 
Honey Type S. aureus SH10000 Ps. aeruginosa PA01 
Manuka honey +20 20 (Appendix figure 1) 20 (Appendix figure 2) 
New Zealand Rewarewa 20 (Appendix figure 3) 20 (Appendix figure 4) 
Nigella sativa 20 (Appendix figure 5) 20 (Appendix figure 6) 
Oak 20 (Appendix figure 7) 20 (Appendix figure 8) 
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4-3-2 Effect of antibiotics on biofilm  
Table 15 shows that the minimum biofilm eradication concentration (MBEC) for the 
antibiotics Erythromycin and Ciprofloxacin (tested only against S. aureus and Ps. 
aeruginosa respectively), not surprisingly was much lower (1.25mg/ml) than that of 
any of the honeys. There is however, no dosage comparability between the antibiotics 
and honeys used here, and the antibiotics, when used in medicine would be taken 
orally, and reach the wound via a systemic route. In contrast, honey is used directly on 
the surface of the wound where it directly interacts with wound pathogens.  
 
Table 15. The minimum biofilm eradication concentration (MBEC) for the antibiotics 
Erythromycin and Ciprofloxacin for S. aureus and Ps. aeruginosa biofilms. 
 
Antibiotic 
Minimum biofilm eradication concentration  
S. aureus SH10000 Ps. aeruginosa PA01 
Erythromycin 
1.25 mg/ml 
(Appendix figure 9) NT* 
Ciprofloxacin NT* 
312 µg/ml  
(Appendix figure10) 
*NT= Not Tested  
 
  The results of this study show that a range of honeys, including Manuka honey are 
able to completely inhibit bacterial biofilms at concentrations above 20mg/ml. Since 
honeys are applied directly to the wound and therefore the associated biofilms, 
concentrations of this order will be inevitably be achieved, when raw honeys are 
applied. As a result, it can be concluded that the honeys used here will inhibit 
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pathogen-biofilms when applied to wounds.  Since antibiotics are often ineffective 
against biofilms the use of undiluted honey provides a potentially effective means of 
controlling pathogen biofilms infected wounds. This killing effect will be even more 
pronounced and lasting since it is generally accepted that bacteria, including 
pathogens, do not develop resistance to honeys. These factors help explaining why 
honeys can be effective when antibiotics are not, especially in the treatment of 
indolent ulcers caused by antibiotic-resistant bacteria.   
As has already been mentioned, honey has historically been long used as a topical 
antimicrobial treatment for infected wounds, with medical products officially 
becoming available from the 1990’s. Medical honey is often still used as a last resort 
when other therapies have proved worthless. 
Manuka honey is a broad spectrum agent with potent bactericidal activity which can 
disrupt the cell cycle in Gram positive bacteria leading to aberrant cell division and 
weakening of the cell wall; this is combined with an up-regulation of the general 
stress response (Jenkins et al., 2011, Roberts et al., 2012). In Gram negative 
organisms, particularly Ps. aeruginosa, the major targets are integral membrane 
proteins e.g. OprF which normally stabilise the cell and without which, membrane 
disruption and eventual lysis occurs (Blair et al. 2009). 
Stewart (2003) claimed that bacterial resistance to Manuka honey treatment has not 
been observed empirically yet. This is of particular importance since antimicrobial 
resistance currently outstrips the rate at which novel antimicrobial approaches can be 
developed and where the development of resistance to all known antibiotics could 
potentially occur. Bacterial antibiotic resistance is exacerbated, when microorganisms 
grow as a biofilm, in which organisms are protected by an extra-polysaccharide layer 
which can restrict the diffusion of antimicrobials. This results in therapeutic doses not 
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reaching all of the bacteria within the biofilm, thereby allowing infection to recur. 
Biofilms, by hindering diffusion, provide an ideal environment in which bacteria are 
exposed to sub-lethal doses of antibiotic thereby providing a selective pressure for the 
increased emergence of resistance. 
   The excessive mis-use of antimicrobial agents has long been recognized as a 
motivator for the emergence of resistant bacterial strains, leading to a correlation 
between the availability of an antimicrobial and occurrence of resistance. This process 
also occurs following the use of topical antiseptics and biocides, including 
chlorhexidine and silver; short and long term, step-wise resistance training has 
demonstrated that neither Ps. aeruginosa nor S. aureus develop resistance to honey 
and that any increased tolerance to treatment is short-lived.  
  Small colony variants (SCV) of the original isolates can emerge in populations of 
bacteria that are exposed to antibiotics (Procter et al.,1998) occurring at a rate of 
1.8×10-8 per cell per generation, and thereby making up a small but persistent 
proportion of the bacterial population. The ability of SCVs to resist antimicrobial 
treatment results from their slow growth and impaired electron transport chain; 
therefore it is not uncommon. Additionally, SCVs characteristically show enhanced 
biofilm formation (Procter et al.,1998) and as a result protection from antibiotics.  
  Wounds often produce exudates and the high osmolarity of honey enhances this 
process, with the result that honey is generally diluted in vivo and that isolates 
exposed to Manuka honey within an established biofilm can develop increased 
resistance, likely the result of the appearance of small colony variants. This problem 
can be avoided in the treatment of recalcitrant or chronic, infected wounds by 
ensuring that medical honeys are appropriately applied for a suitable length of time in 
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combination with other antimicrobials where necessary to ensure that the infection is 
cured and that any likelihood for resistance is thereby minimised. 
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Chapter 5  
Effect of Honey on Pyocyanin Production by   
Ps. aeruginosa and Biofilm Formation by         
Ps. aeruginosa and S. aureus 
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5-1 Introduction 
       It is essential that we reduce the prevalence of antibiotic resistant bacteria which 
are being spread rapidly due to the selection of strong and resistant strains from weak 
strains within antibiotic treated populations. There is an indirect way by which this 
reduction can be achieved, namely by altering the ability of bacteria to become 
pathogenic by disabling or disrupting bacterial communication i.e. by disrupting 
quorum sensing. When this is achieved, the host is not compromised by inflammation, 
toxicity, cell damage or any other virulence factors, thereby allowing the body to 
eradicate the bacteria naturally by employment of the immune system. Quorum 
sensing (or bacterial cell signalling) describes a natural phenomenon whereby a single 
bacterium senses the accumulation of a population through signalling molecules. It 
then communicates with other bacteria inside the population allowing them to work 
together in order to adapt to changes, which might occur in the immediate 
environment. Quorum sensing was first observed in Vibrio fischeri, a bioluminescent 
bacteriumthat lives as a mutualistic symbiont in the photophore (light producing 
organ) of the Hawaiian bobtail squid. It was found that the bacteria do not 
showluminescence at low concentrations in the free-state. However, when bacteria are 
present in the photophore at high concentrations (roughly 1011cells/ml) 
bioluminescence occurs as the transcription of luciferase is induced. Many diverse 
networks are maintained by quorum sensing including: biofilm formation – 
sporulation – motility – antibiotic production – conjugation – competence – virulence 
and symbiosis (Miller and Bassler, 2001). 
Two inducing molecules have been identified in bacteria which control quorum 
sensing, namely, oligopeptides in Gram-positive bacteria (Novick et al., 1993), and 
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acylated homoserine lactones (AHLs) in Gram negative bacteria (Galloway et al., 
2011). 
   The accumulation of AHLs occurs because fluctuations in the bacterial population 
activate the quorum sensing systems. The core of a quorum sensing system has two 
genes; the LuxI gene, which is responsible for the production of AHL, and the LuxR 
gene, which is responsible for the production of a protein able to bind AHL with the 
target gene on the DNA. A definite type of AHL then activates a specific type of R 
protein (Figure 19). 
 
Figure 19. Quorum sensing circuit (Winans and Bassler, 2002) 
 
The AHL signal molecule consists of two parts, a homoserine lactone ring and a fatty 
acyl side chain which differs in the length; it can be either saturated or unsaturated or 
consists of an oxo group or a hydroxyl at the third carbon. Different types of AHL 
molecule can be found in different species as shown in Figure 20. 
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Figure 20. The AHL molecule in some bacterial species (Chemical and Engineering 
News website) 
 
5-1-1 Quorum sensing in Ps. aeruginosa 
In Ps. aeruginosa, genes encode virulence factors and the synthesis of some important 
products for bacteria; host interactions are also controlled by quorum sensing system 
(Van Delden and Iglewski, 1998, Favre-Bonte et al., 2003). The following two 
networks direct quorum-sensing system in Ps. aeruginosa: 
1- The acyl-homoserine lactone (AHL) or LasR/RhIR network (Fuqua et al., 
2001). 
2- The 4-hydroxy-2-alkylquinolines (HAQs) or MvfR regulatory network 
(Gallagher et al., 2002) 
Both networks are involved in the regulation of a wide variety of virulence factors and 
biofilm synthesis (Wang et al., 2012). Zhu et al. (2002) claim that the level of AHLs 
production in Ps. aeruginosa is associated with the intensity of the infections, which 
means that AHL production, differs among the same species. Pathogenicity of Ps. 
aeruginosa is attributed to the production of pyocyanin as well as some enzymes. 
Pyocyanin is a blue soluble dye observed in mucous samples of some patients with 
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bronchitis; it promotes virulence by interfering with several cellular functions in host 
cells including cellular respiration, electron transport, gene expression, energy 
metabolism, and innate immune mechanisms (Rada and Leto, 2013). Pyocyanin 
exhibits antimicrobial activity against a wide range of microorganisms; however, it 
cannot be used as an antibiotic because it is toxic to human airway epithelial cells and 
may cause cancer (Denning et al., 1998, Rada et al., 2008).  
    Some natural products decrease the production of virulence factors by inhibition of 
quorum sensing. Mihalik et al., (2007)suggested that Camellia sinensis or green tea 
significantly inhibits quorum sensing in Ps. aeruginosa and subsequently, the 
inhibition of virulence factors such as pyocyanin production, swarming motility, 
proteolytic activity observed.  It has also been shown that honey at low concentration 
inhibits the expression of MufR, las, and rH regulons which are associated with 
virulence factors production such as pyocyanin in Ps. aeruginosa(Wang et al., 2012). 
  In addition to virulence factors, honey at low concentration of (0.1 g/ml) has anti-
quorum sensing activity, with the inhibition activity increasing with increases in 
honey concentration (Truchado et al., 2009b). Acacia and polyfloral honey also 
reduces biofilm formation significantly in E.coli O157:H7 but not in commensal 
strains of E.coli (Lee et al., 2011). Biofilms of S. aureus, methicillin resistant S. 
aureus (MRSA), vancomycin resistant Enterococcus (VRE) can all be influenced in 
vitro with concentrations of Activon Manuka honey above 10% (W/V) (Cooper et al., 
2011a), and  a Chestnut honey variety was shown to prevent biofilm formation of 
Erwinia cartovora, Yersinia enterocolitica and Aeromonas hydrophilia through 
quorum quenching (Truchado et al., 2009a).  
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The overall aim of the work reported in this Chapter was to study the effect of honey 
at different concentrations on the production of the virulence factor pyocyanin and 
biofilm formation of Ps. aeruginosa. 
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5-2 Material and Methods 
5-2-1 Pyocyanin assay 
Five antibacterial types of honey (New Zealand Rewarewa, Manuka +20, Oak, 
Nigella sativa and New Zealand Rainforest +30) were tested for their effectiveness on 
the pyocyanin production as described by Wang et al., (2012). Ps. aeruginosa Boston 
strain ATCC 27853 was grown in Pseudomonas broth, which is recommended for the 
detection of pyocyanin production by Pseudomonas species (Appendix 6). 
5-2-1-1 Inoculum preparation 
        More than 20 colonies of the same morphological appearance from a fresh 
subculture of the bacteria under test were picked off with a sterile loop and dipped 
into 5 ml sterile phosphate buffer to produce inoculums density equal to McFarland 4 
(12x108 CFU).1 ml was taken with sterile pipette and transfer to 49 ml of double 
strength media. 
5-2-1-2 Honey dilutions 
Honey concentrations of 40%, 20% and 10% were prepared in individual sterile tubes. 
Diluted honey (5ml) was transferred into sterile tube and mixed with 5 ml of the 
previously prepared bacterial inoculums to give final concentrations of 20%, 10% and 
5%. Sterile distilled water was used as a negative control and a positive control was 
set up at the same time. Tubes were kept overnight in 370C aerobic incubator (Baron 
and Rowe, 1981). 
5-2-1-3 Minimum bactericidal concentration 
A loopful (approximately 10 µl) of culture was streaked out from each tube on a 
nutrient agar plate and was incubated for 24 hrs at 370C. 
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5-2-1-4 Pyocyanin extraction 
Pyocyanin was extracted from cultures after 24 hrs of incubation. Tubes were 
centrifuged and 3 ml of supernatant was pipetted into a sterile tube and mixed with 1 
ml of chloroform (Figure 21). The chloroform layer was then transferred to a fresh 
tube and mixed with 1 ml 0.2 M HCL. The top layer was removed and its absorption 
measured at 520 nm. 
 
Figure 21. Pyocyanin (in blue) was extracted by mixing with Chloroform 
 
5-2-1-5 Pyocyanin standard curve 
Concentrations of 50, 25, 12 and 6 µl/ml of pure pyocyanin (Sigma Aldrich, UK) 
were prepared in sterile distilled water. Chloroform (1ml) was added to the pyocyanin 
solution with mixing and left for a minute to allow the pyocyanin layer to separate. 
The supernatant was discarded and 1 ml 0.2 M HCL was added with mixing. The 
upper reddish coloured layer was measured in spectrophotometer at 520 nm, and the 
OD was applied to a pyocyanin calibration curve equation. All experiments were 
conducted in triplicate.  
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5-2-2 Effect of honey on non-established biofilms 
        Polystyrene 96-well assay plates with flat bottoms supplied by CEESTAR® were 
used and the method described by Cooper et al., (2011a) was used . 
5-2-2-1 Inocula preparation  
        More than seven colonies of the same morphological appearance of a fresh 
subculture of the tested bacteria were picked off with a sterile loop and dipped into 30 
ml sterile nutrient broth.  
5-2-2-2 Preparation of the honey serial dilutions 
    Concentrations of 80% of the effective honeys (New Zealand Rewarewa, Manuka 
+20, Oak, Nigella sativa and New Zealand Rainforest +30) were prepared in sterile 
tubes and then 200 µl was transferred to the third wells in the first five rows 
respectively. The vertical well line was used for one type of honey from the third row 
to the eleventh row. The test for each type of honey was done in duplicate. The entire 
sixth row used as positive control and the first two wells of each column were used as 
negative controls. The remaining wells were filled with 100 µl of sterile distilled 
water.By using a multi-channel pipettor; 100 µl was taken from the third row and 
transferred to the adjacent well with slow pipetting and decanting. The same protocol 
was applied to all wells to make serial fold dilutions from 80% to 0.32%.  
5-2-2-3 Bacterial inoculation 
Bacterial suspensions (100 µl) were added to all wells, which had the diluted honey 
and mixed thoroughly to give dilutions from 40% to 0.16%. The plates were then 
incubated at 370C for 24hrs.  
5-2-2-4 Plate reading  
After the incubation period, liquid culture was dislodged by pipetting 200 µl from all 
wells. All wells were then washed with 210 µl of sterile distilled water twice to insure 
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that most of the planktonic cells were removed; the plates were then left in the oven to 
dry at 550C. In order to stain the biofilm, 50 µl of crystal violet was dispensed inside 
the wells and left for 5 min, followed by washing with sterile distilled water twice and 
then drying in the oven. The amount of dye retained reflects the amount of biofilm 
present. The stained biofilm was extracted with 200 µl of 30% acetic acid, added to 
all wells and allowed for 30 min to dissolve the adhered protein around the wells. The 
plate was measured at OD595 in the plate reader (Figure 22). 
 
 
Figure 22. Different concentrations of different types of honey stopped the biofilm 
formation of S. aureus 
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5-3 Results and Discussion 
5-3-1 Effect of honey on Pyocyanin production  
Table 16 shows the production of pyocyanin by Ps. aeruginosa as influenced by a 
range of honeys. The table shows minimum bactericidal concentrations for the honeys 
and pyocyanin inhibition concentrations. When the two values are the same this 
means that the honey has killed the bacterium without influencing the pyocyanin 
concentration. When the opposite is found, then the honey has reduced pyocyanin 
production. This means that a small concentration of honey stopped the production of 
pyocyanin by the bacterium, a compound that can be toxic to humans. This means that 
where the concentration of honey does not kill Ps. aeruginosa it nevertheless inhibits 
the production of the human toxicant pyocyanin. Manuka, Oak and Rain Forest 
honeys were seen to inhibit pyocyanin production without killing bacteria. 
 
Table 16.  The minimum concentration of honey that inhibits the growth and 
production of pyocyanin for Ps. aeruginosa 
 
Minimum 
Bactericidal 
Concentrationof 
honey(mg/ml) 
Minimum pyocyanin 
inhibition 
concentration of 
honey(mg/ml) 
Appendix 
Figures 
 Honey Type 
Manuka honey +20 20 *10 12 
New Zealand Rewarewa 20 20 13 
Nigella sativa honey 20 20 14 
Oak 20 *10 15 
Rainforest +30 10 *5 16 
 
* A honey concentration is considered to be significant when the minimum biofilm 
inhibiting concentration is less than the minimum bactericidal concentration. 
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5-3-2 Effect of honey on biofilm formation  
Table17 shows an alternative approach to testing honeys on biofilms. In this case 
different concentrations of honeys where mixed with bacteria and the biofilm was 
then left to develop. This contrasted with the former approach, where the biofilm was 
pre-formed and the honey was added. Inhibition of quorum sensing networks by 
honey is associated with sugar content (Wang etal., 2012). 
 
Table 17. The minimum concentration of honey that inhibits the formation of biofilm 
for S. aureus and Ps. aeruginosa 
 
 
Minimum biofilm inhibiting concentration / Minimum 
Bactericidal Concentration (MBC) (mg/ml) 
Honey Type 
S. aureus 
SH10000 
Appendix 
Figures 
Ps. aeruginosa 
PA01 
Appendix 
Figures 
Manuka honey +20 10/20* 17 20/20 22 
New Zealand Rewarewa 20/20 18 20/20 23 
Nigella sativa 20/20 19 20/20 24 
Oak 20/20 20 20/20 25 
Rainforest +30 5/5* 21 5/10* 26 
 
* A honey concentration is considered to be significant when the minimum biofilm 
inhibiting concentration is less than the minimum bactericidal concentration. 
 
The results obtained in this Chapter provide strong evidence to use honey as a 
prophylaxis agent inside the body since honey consumption is likely to prevent 
biofilm formation within body tissues and also reduce pyocyanin toxicity.  Clearly, 
honey interacts, at low concentrations, with some pathogenic traits such as biofilm 
formation and toxin production. In the case of biofilm formation, Manuka honey stops 
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the formation of biofilms of S. aureus at a concentration of 10 mg/ml and Rainforest 
honey +30 prevents biofilm formation by S. aureus and in the case of Ps. aeruginosa 
at 5 mg/ml. Manuka +20, Oak and Rainforest +30 were effective in preventing 
pyocyanin production by concentrations of 10, 10 and 5 mg/ml respectively. So, it 
was assumed that the active component in honey reaches the infection or colonized 
site inside the body, even though, its concentration may be reduced tenfold in the 
body. However, more investigations are needed to support the possibility of 
consuming honey as a prophylaxis agent and to test honeys against different types of 
pathogens possessing different pathogenic traits. Clearly in vivo studies will be 
required here. 
It is becoming increasingly obvious that honey impacts on the virulence of bacterial 
pathogens in addition to affecting both the organism’s cellular structure and 
metabolism. This is a useful attribute for an antimicrobial agent allowing studies 
devoted to novel ways of attacking bacterial infection to begin to focus on anti-
virulence treatments rather than traditional bactericidal or bacteriostatic properties. 
The major advantage of this approach is that anti-virulence formulations do not bring 
about the same selective evolutionary survival pressure that encourages the 
emergence of resistance. Three recent studies have described the mechanism by which 
honey inhibits quorum sensing and virulence (Lee et al., 2011, Wang et al., 2012).The 
concentrations of honey that brought about this effect were far below the MIC. 
Biofilm formation by E.coli O157:H7 was disrupted by sub-lethal doses of honey, 
which was associated with the repression of quorum sensing genes. Concurrently, a 
reduction in the expression of genes encoded on the locus of enterocyte effacement 
and curli genes (csgBAC) was noted, both of the operons being known for their 
ability to play a significant role in the virulence of this bacterium (Lee et al., 2011) 
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Similarly, sub-inhibitory concentrations of honey have been shown to impair quorum 
sensing in Ps. aeruginosa by reducing the expression of the las and rhl regulons 
and the transcriptional regulator MvfR (Wang et al., 2012). Perturbation of these 
regulatory networks resulted in a reduction in the expression of associated virulence 
factors, clearly demonstrating the overall impact that honey exhibits on the bacterial 
cell at the regulatory level. N-acyl-homoserine lactone production has also been 
shown to be significantly reduced in Erwinia carotovora, Yersinia enterocolitica 
and Aeromonas hydrophilain response to chestnut honey. As was the case for E. 
coli, biofilm formation was also impaired, again emphasizing the close association 
between these two processes (Truchado et al., 2009).Biofilm formation and 
expression of virulence factors are fundamental to the successful colonization and 
subsequent pathology of many bacterial infections; thus, by impairing this process 
honey could prove to be an excellent prophylactic agent. 
    Another group of virulence factors that are known to be regulated by quorum 
sensing in numerous pathogenic microorganisms are the siderophores. Such iron-
chelating molecules are central to bacterial proliferation in the host environment, 
providing pathogens with a source of iron; iron acquisition being directly linked to 
virulence. Pyocyanin, pyochelin and pyoverdin are all utilized by Ps. aeruginosato 
sequester iron from the human host (pyoverdin and pyochelin are siderophores, 
whereas pyocyanin appropriates iron from transferring) (Cox 1986). In different 
strains of Ps.aeruginosa, honey treatment was shown to bring about a marked 
reduction in siderophore production the effect being attributed to sub lethal doses as 
low as 5% (w/v) which equated to quarter of the MIC (Kronda et al., 2011).The 
reduced production of pyocyanin following honey treatment mirrors a reduction in 
expression of genes involved in quorum sensing, demonstrating the global impact that 
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altered gene expression has on the expression of virulence factors (Wang et al., 2012). 
The reduced capacity of pathogenic bacteria to obtain iron from their host will be 
obviously detrimental to both colonization and to the subsequent sequence of the 
infection process. These mechanisms show that honey works via two independent 
mechanisms, i.e. by being both bactericidal and anti-virulent, a combination of 
properties, which is unlikely to initiate and promote bacterial resistance. 
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Chapter 6 
The Effect of Some Wound Dressings and 
Treatments on Planktonic Bacteria and 
Bacterial Biofilm 
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6-1 Introduction 
In relation to wounds, there are many indications, which should be identified before 
practitioner decides whether the patient needs treatment, or not. Firstly, bacterial 
contamination may be normal and does not alter the status of the wound or affect the 
host. Normal colonization is associated with unremarkable symptoms, while critical 
colonization is associated with moderate pain and a discharge, which is attributed to 
the presence of a heavy burden of bacteria in the wound. True infection results when 
pathogens develop inside the wound and leads to clinical infection with increasing 
cellulites (inflammation and infection of the tissue), bad odour, irresistible pain and 
heavy discharge. Infections can be focal point of some severe consequences such as 
bacteraemia – septicaemia – meningitis (Benbow, 2005). 
   Microbial populations compete for local nutrients, secrete destructive enzymes or 
cytotoxic metabolites and inhibit both host tissue regeneration and immune responses 
(Thorn et al., 2009). 
The main barrier to the normal healing process of the wound is the bio-burden, which 
includes: 
1- Colonizing microorganisms of one or more bacterial species. 
2- Devitalized tissue which provides a solid surface for the biofilm to grow on 
(White and Cutting, 2006). 
Antimicrobial agents only effectively affect planktonically growing bacteria and 
metabolically active bacteria but not bacteria in an inert state (Davey and O'Toole, 
2000). The deeper the biofilm, the more inert the population tends to be; therefore, the 
metabolic activity of the bacteria varies with biofilm depth (Davies, 2003, Sternberg 
et al., 1999).It has been shown that biofilms are the main cause of treatment failure 
and acute wounds which because of their presence can be turned into chronic, non-
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healing wounds (Bjarnsholt et al., 2008, Davis et al., 2008, James et al., 2008); the 
treatment of such chronic wounds is generally more expensive than acute wounds 
(James et al., 2008). 
Biofilms presented in wounds are generally made up of more than one species of 
bacteria, which make the exchange of drug resistance genes easier and thereby 
enhance bacterial resistance (Cookson, 2005, Davies, 1994). Hill et al. (2010) for 
example showed that a mixture of Ps. aeruginosa and S. aureus biofilm was not 
affected in vitro by treating with high concentrations of Ciprofloxacin (5 mg/L) or 
Flucloxacillin (15mg/L).  
 
6-1-1 Wound dressings 
Dressings provide the wound with appropriate protection from environmental 
contaminants and allow the wound to heal under dry conditions (Benbow, 2005). In 
addition to antimicrobial compounds, most dressings maintain wound hydration by 
containing compounds such as alginate, foam, hydrogel and hydrocolloids (Bradshaw, 
2011). 
Kostenko et al.(2010) reported that the type of dressing-base material is correlated 
with the antimicrobial effectiveness of the dressing. Even though, most dressings used 
in hospitals have antimicrobial activity,Bradshaw (2011), claimed that an appropriate 
dressing should be selected after the determination of the bacterial species present 
within the wound. Some medical dressings are used nowadays with additives such as 
silver dressings, honey dressings, and iodine. 
6-1-2 Silver dressings 
Silver has a wide range of actions on bacteria, unlike antibiotics; it affects the 
respiratory system, cell membrane integrity, transmembranous energy, electrolyte 
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transport, enzyme activities and cell proliferation (Lansdown, 2002). Moreover, silver 
decreases bacterial adhesion by compromising intermolecular forces (Chaw et al., 
2005, Klueh et al., 2000). Silver is released effectively in wound environments with a 
high level of hydration (Lansdown et al., 2005), so the more fluids and exudates from 
the wound, the more effective the silver dressings is (Sibbald et al., 2003). Silver 
dressings achieve marked biofilm inhibition and every type of silver dressings 
exhibits  different activity on bacterial biofilms (Percival et al., 2007).  The whole 
bacterial community in the biofilmof Ps. aeruginosa and S. aureus can be killed after 
48 hours when exposed to a silver dressing (Percival et al., 2008); this finding did not 
however, correlate well within vivo observations (Heggers et al., 2005). The silver 
concentration used in the medical dressing is generally insufficient to eradicate 
chronic wound biofilms (Kostenko et al., 2010), the complete eradication of which 
requires a silver concentration in excess of 10 – 100 times than that used to treat the 
planktonic bacteria. In vitro Ps. aeruginosa biofilm were however shown to be 
successfully inhibited with silver concentrations of 5-10µg/ml (Bjarnsholt et al., 
2007). 
6-1-3 Honey dressings 
The effectiveness of honey is related to many factors:   
1. Osmolarity which prevents the bacteria from growing and supports healing 
process (Moore et al., 2001). 
2. Acidity making it an unsuitable medium to grow on (Gethin et al., 2008) 
3. Hydrogen peroxide which is released when the honey is diluted with wound 
exudates (Kwakman et al., 2010). 
4. Flavonoids and phenolic acid compounds which support the immune system 
and kill bacteria (Escriche et al., 2013). 
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5. Some unique compounds which exist only in certain types of honey such as 
methylglyoxal, which is found in Manuka honey (Kwakman and Zaat, 2012). 
Gethin et al., (2008) reported that Manuka honey dressings significantly minimized 
the pH and the extent of the chronic wounds and may thereby contribute to wound 
healing. In addition, it has been reported that honey dressings increase healing, 
prevent the formation of scab on burns, sterilise the wound, deodorize wounds, 
increasing and separating sloughs, reduce pain and finally minimize the formation of 
scars (Al-Waili et al., 2011).Treatment with honey was also reported as a successful 
therapy for various wounds, such as ulcers, abdominal pain and burns (Sharp, 2009, 
Topham, 2002).  
In a comparison study between honey dressing, ampicillin ointment and saline 
treatment, honey was shown to lead to the least inflammation, epithelisation and the 
most active fibroblastic and angioblastic activity (Gupta, 1992).  In a similar study 
honey was found to be more effective than both antiseptics and antibiotics in the 
treatment of wounds infected or colonized with methicillin resistant S. aureus 
(MRSA) (Blaser et al., 2007a). Medihoney dressing have been found to be highly 
effective therapy especially following the failure (after 12 weeks) of conventional 
therapies (Dunford and Hanano, 2004). Honey dressings are also more effective at 
promoting wound healing and less painful than sugar dressing (Mphande et al., 2007). 
According to clinical studies, wounds became sterilize in 3 to 10 days following the 
use of honey dressings (Van der Weyden, 2003, Mossel, 1980, Tovey, 1991). 
Moreover, the duration of healing and hospital stay is decreased after wounds are 
washed with normal saline and the honey is applied with covering by dry gauze 
(Efem, 1988). 
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6-1-4 Hand gel (Non honey based) 
Hand contact is responsible for the transmission of infections (Zanni, 2008).There are 
two types of skin flora, a) the resident flora which colonizes deeper skin layers with 
low potential of pathogenicity, long stay and high resistance to mechanical removal, 
e.g. both S. epidermidis and Streptococcus viridians, and b) the transient flora on the 
other hand colonizes the outer skin layer for short period and with a moderate or high 
potential of pathogenicity, e.g., S. aureus and colifom bacilli (Widmer, 2000). Hand 
gels (alcohol-based rubs) provide an instant and effective approach for use in 
hospitals (Marchetti et al., 2003), although as Pietsch (2001) pointed out, alcoholic 
gels are not always effective when used in hospitals as they do not meet the 30 second 
European standard for hand disinfectants (EN 1500). 
6-1-5 Iodine 
Iodine is active against proteins and enzymes and works by coupling thiol and 
sulphydryl groups, and blocks hydrogen bonding which alters phospholipids 
membrane structures (Leaper and Durani, 2008). Iodine is active on bacteria, fungi 
and viruses, although its human toxicity can undermine its medical use (Bradshaw, 
2011). 
 
The aims of the work reported in this Chapter were to: 
1- Evaluate the effectiveness of some types of medically used dressings. 
2- Test various dressings on biofilm containing pathogenic bacteria. 
3- Test a variety of wound treatments against pathogenic bacteria. 
4- Test various wound treatments on biofilm containing pathogenic bacteria. 
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6-2 Materials and methods 
6-2-1 Tested organisms and used media 
Two types of the most common causing wounds infection bacteria were tested, 
namely Staphylococcus aureus SH1000 and Pseudomonas aeruginosa PA01; the 
bacterial inoculum was prepared as described in the Appendix 1. 
The following media were used: 
1- Brain and Heart infusion agar (BHI): the best media for growing biofilms of S. 
aureus. 
2- Pseudomonas agar base ISO 13720 (ISO): the ideal medium for growing biofilms 
of Ps. aeruginosa. 
3- Nutrient agar (NA): used for bacterial plate counts. 
4- Nutrient broth: used to enrich bacterial suspensions. 
5- Muller Hinton Agar (MHA): for the sensitivity test. 
6-2-2 The effect of wound dressings and creams on planktonic bacteria 
6-2-2-1 Dressing tests 
Four types of wound dressings were tested for their effectiveness as follow: 
1. Askina© Calgitrol© Ag. 
2. Actilite© (a non-adherent dressing containing Activon Manuka honey). 
3.  Algivon© (Alginate containing active Manuka honey). 
4. Algivon© (Alginate dressing impregnated with 100% Manuka honey). 
 The dressing were cut into small pieces with size of 12 mm and kept in sterile, empty 
Petri dishes until used. Muller Hinton agar plates were inoculated with bacteria broth 
and incubated at 370C for 30 minutes. The dressings were then replaced on the plate 
in three corners with the control placed in the remaining corner (Figure 23). The 
plates were incubated in 370C for 24 hrs.    
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Figure23.The effect of some wound treatments on planktonic bacteria 
 
6-2-2-2 Creams tests 
Three types of wound creams, Panaderm*, Activon Manuka honey and Flamazine* 
and a hand sterilizer* were tested for their antibacterial properties.  
Three wells were cut in three corners in the plate to dispense the antibacterial cream 
inside and left in the incubator after inoculated with bacterial suspension for 24hrs in 
370C.  
*Panaderm is a cream consisting of three types of antibiotics (neomycin sulphate 2.5 
mg, Nystatin 100.000 units and gramicidin 0.25 mg).  
* Flamazine contains silver as active ingredient. 
* The active ingredient in the hand sanitizer is isopropanol. 
 
6-2-3 Effect of wound dressings on the bacterial biofilms 
6-2-3-1 Wound dressings  
Three types of wound dressings obtained from different companies as detailed below: 
1- Silver (Askina© Calgitrol© Ag) referred to here as Ag. 
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2- Actilite© (a non-adherent dressing with Activon Manuka honey) which is referred 
to here as NAD. 
3-Algivon© (an alginate dressing impregnated with 100% Manuka honey) which is 
referred to here as M. 
All types were tested against the following: 
1- Biofilm formation: where the biofilm are not established. 
2- Activity on established biofilm, examined after 24 hrs and 48 hrs of dressing 
application. 
6-2-3-2 Nitrocellulose membrane preparation 
Nitrocellulose membranes of 25 mm diameter supplemented by Millipore© were used 
to create the biofilm. All membranes were soaked into phosphate buffer solution 
(Sigma Aldrich) for 24 hrs before being transferred into bacterial inoculum tubes. 
6-2-3-3 Colony biofilm assay 
Protocol 3 described by Merritt et al., (2005) was applied. All membranes were 
soaked into phosphate buffer solution for 24 hrs and then transferred into adjusted 
bacterial suspension media and left for 15 minutes. By using sterile forceps, 
membranes were applied to the surface of agar media and incubated down side down 
in 370C for 48 hrs until renewing on new plates for 48 hrs more to enrich the growth 
of the biofilm. 
6-2-3-4 Positive control 
After 96 hours of incubation, three membranes were removed from the media and 
washed in sterile phosphate buffer in order to remove all planktonic cells; these were 
then transferred into 10 ml separate tubes of sterile phosphate buffer solution and then 
transferred to a sonicator bath for 1 hour to release all viable cells. The tubes were 
finally vortexed for 30 seconds to homogenize the suspension. (1 ml) was transferred 
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to 9 ml phosphate buffer to make dilutions of 10-1, serial dilutions were then made up 
to 10-6. Aliquots (100 µl) were taken from all tubes and spread on nutrient agar plate 
by use of a spreader and incubated for 24 hrs to obtain the colony forming unit count 
(CFU) present in of the main tube. All counts are given as the mean of triplicates. 
6-2-3-5 Dressing application 
After 96 hrs of incubation, the membranes were removed from the old plates and 
washed with sterile phosphate buffer solution to remove all planktonic cells then they 
were transferred to new plates. Distance was standardized by placing them in each 
edge of the plate (Figure 24). The dressings were cut into square shape with diameter 
of 30mm to cover all membrane’s sides. The plate contained four membranes with 
three pieces of the same dressing as follows: 
1- Negative control: a membrane soaked in phosphate buffer without bacteria. 
2- Non established biofilm: this membrane was neutralized in Phosphate buffer for 24 
hrs after that it was soaked in bacterial suspension for 15 minutes. 
3- Established biofilm: a membrane with established biofilm and this was tested after 
24 hrs. 
4- Established biofilm: a membrane with established biofilm and this was tested after 
48 hrs. All were done in triplicate. 
 
Figure 24. Membranes contain biofilm covered with dressings in different cases 
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6-2-3-6 Dressing recovery 
After 24 hrs of incubation all dressings were removed except one, which examined 
after 48 hrs. All of the membranes were taken off the media and washed in sterile 
phosphate buffer to remove all planktonic cells then transferred into 10 ml separate 
tubes of sterile phosphate buffer solution and transferred to a sonicator bath for 1 hour 
to release all viable cells. Tubes were vortexed for 30 seconds to homogenize the 
suspension.1 ml was then transferred to 9 ml phosphate buffer to make a dilution of 
10-1, serial dilutions were then made up to 10-6. An aliquot (100 µl) was taken from all 
tubes and spread on nutrient agar plate using a spreader and incubated for 24 hrs to 
obtain the colony forming unit (CFU) of the main tube. All counts are the means of 
triplicates. The same procedure was performed on the 48 hrs dressings. 
6-2-4 The effect of wound creams on bacterial biofilms 
Four wound treatments were tested as follows: 
1- Panaderm© cream: effective against Gram negative and Gram positive bacteria as 
well as fungi. 
2- Flamazine© cream: active component is silver. 
3- Activon© cream: active component is Manuka honey. 
4- A hand sterilizing agent. 
The minimum biofilm eradication concentration (MBEC) was determined using the 
MBECTM High-Throughput (HTP) Assay (Innovotech, Canada) (Appendix3). 
6-2-4-1 Preparing the antimicrobial challenge plates 
 The horizontal wells were used for one type of treatment from the ninth column to 
the twelfth column. The test for each type of treatment was done in the whole column. 
The fifth and sixth columns were removed by using sterile metal pliers to use these 
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rows as negative controls afterward whereas the first, second and third columns were 
used as positive controls (Figure 25).  
 
 
Figure 25. A challenge plate contains some wound treatments 
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6-3 Results and Discussion 
6-3-1 The activity of some dressings on planktonic bacteria 
Four types of dressings were tested against S. aureus and Ps. aeruginosa. Figure 
26shows that all of dressings impregnated with Manuka honey exhibited greater 
antibacterial activity against S. aureus than the one containing silver. The most 
effective type of honey dressing was Actilite© (Non-adherent dressing containing 
Activon Manuka honey) followed by Algivon© (Alginate with action Manuka honey) 
and Algivon© (Alginate dressing impregnated with 100% Manuka honey) with zone 
diameters of 32, 25 and 19 mm respectively. The one silver dressing used on the other 
hand was more effective than Manuka honey dressings against Ps. aeruginosa (zone 
diameter 24 mm) (Figure 27). 
 
6-3-2 The activity of some wound treatments on planktonic bacteria 
A range of wound treatments, such as antibiotics, honey, silver and hand gel were 
tested on S. aureus and Ps. aeruginosa (Figure 28, 29). Panaderm, a mixture of 
antibiotics was the most effective treatment against S. aureus and Ps. aeruginosa 
(zone diameter, 25 mm). Activon Manuka exhibited remarkable activity against S. 
aureus (zone diameter 19 mm) and moderate activity against Ps. aeruginosa (zone 
diameter 12 mm). Flamazine showed moderate activity against S. aureus and Ps. 
aeruginosa (zone diameters, 14 and 16 mm respectively). The hand gel showed weak 
activity on both types of bacteria. Al Zahrani and Baghdadi, (2012) claimed that 
among seven tested types of hand sanitizers only two were effective and suitable for 
use as anti-bacterial agent. 
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Figure 26. The effect of some wound dressings on the planktonic Staphylococcus 
aureus (* Significant differences) 
 
Ag= Askina© Calgitrol©. 
AC= Actilite© (a non-adherent dressing containing Activon Manuka honey). 
AM= Algivon© (Alginate containing active Manuka honey). 
AAM= Algivon© (Alginate dressing impregnated with 100% Manuka honey). 
 
 
 
 
 
 * 
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Figure 27. The effect of some wound dressings on the planktonic Pseudomonas 
aeruginosa (* Significant differences) 
 
Ag= Askina© Calgitrol©. 
AC= Actilite© (a non-adherent dressing containing Activon Manuka honey). 
AM= Algivon© (Alginate containing active Manuka honey). 
AAM= Algivon© (Alginate dressing impregnated with 100% Manuka honey). 
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Figure 28. The effect of some wound treatments on the planktonic Staphylococcus 
aureus (* Significant differences) 
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Figure 29. The effect of some wound treatments on the planktonic of Pseudomonas 
aeruginosa (* Significant differences) 
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6-3-3 Effect of wound dressings on the bacterial biofilm 
Three types of dressings were tested in three different types of biofilms of S. aureus 
and Ps. aeruginosa. Biofilms were tested: the inocula, at the outset before the biofilm 
formed and after formation at 24hrs and 48 hrs.  
Figure 30shows the effects of a variety of antibacterial dressings on the three types of 
biofilms. All of the Manuka dressings brought about complete biofilm inhibition after 
0, (representing biofilm initiation) 24 and 48 hrs. In contrast the silver dressings 
achieved only 99% and 86 % inhibition of biofilm formation after 24 and 48 hours. 
Figure 31 shows that with the exception of the NAD dressing all of the dressings kill 
all the biofilm Ps. aeruginosa at 0, 24 and 48 hours. 
 
Figure 30. The killing activity of some dressings on the biofilm of S. 
aureus(Appendix figure 27) 
Ag = Silver (Askina© Calgitrol© Ag) 
NAD = Actilite© (a non-adherent dressing with Activon Manuka honey)  
M= Algivon© (an alginate dressing impregnated with 100% Manuka honey)  
NEB= Non Established Biofilm  
EB24= Established Biofilm for 24 hrs 
EB48= Established Biofilm for 48 hrs 
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Figure31. The killing activity of some dressings on the biofilm of Ps. 
aeruginosa (Appendix figure 28) 
Ag = Silver (Askina© Calgitrol© Ag) 
NAD = Actilite© (a non-adherent dressing with Activon Manuka honey)  
M= Algivon© (an alginate dressing impregnated with 100% Manuka honey)  
NEB= Non Established Biofilm  
EB24= Established Biofilm for 24 hrs 
EB48= Established Biofilm for 48 hrs 
 
6-3-4 Effect of wound treatments on the bacterial biofilm 
All four products inhibited S. aureus biofilm formation, with Panaderm showing the 
most effect, (90% inhibition), while Flamazine Activon and the Hand Gel exhibited 
around 70% inhibition (Figure 32).The effect of the antibacterial creams and the hand 
gel on the Ps. aeruginosa biofilm is shown in Figure (33). The order of inhibition is 
seen to be Panaderm, Flamazine and Activon, with the Hand Gel having no effect. In 
all cases the products used here exhibit differing effects of the bacteria studied. 
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Figure 32.Effect of various cream products and a hand gel on biofilm of S. aureus (as 
measured by minimum biofilm eradication concentration technique).(Appendix figure 
29). 
 
Figure 33.Effect of various cream products and a hand gel on biofilm of Ps. 
aeruginosa (as measured by minimum biofilm eradication concentration technique) 
(Appendix Figure 30). 
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Many patients suffer from a profoundly suppressed immune system, especially when 
caused by leukaemia and chemotherapy which they have to undertake, a problem 
which frequently results in wound-healing problems (Simon, 2006, Gaur, 2005), such 
that the patients are susceptible to wound infections which spread rapidly in  
immunocompromized patients, often leading to potentially life-threatening 
bloodstream infections (Gaur 2004). Such patients can be treated effectively with 
honey based dressings. An example of the use of medical honey dressings is provided 
by the case of a 12-year old patient who had an abdominal lymphoma removed such 
that it left an open abdominal drainage site (Molan, 2002, 2006). When admitted, the 
wound was infected with methicillin-resistant Staphylococcus aureus (MRSA). The 
male patient was immediately isolated to avoid nosocomial spread. The wound was 
then treated with a local antiseptic (octenidin) for 12 days. When no improvement 
took place an Australian medical honey dressing (Medihoney™), was applied. Two 
days later, the wound was free of bacteria and chemotherapy against the underlying 
illness could begin.  Medihoney™ became one of the first medically certified honeys 
licensed as medical product for medical use on wounds, both in Europe and Australia 
(Molan, 2004, 2006). In addition to having antibacterial properties, medical honey 
increases the rate at which wounds heal through its anti-inflammatory effects by 
reducing oedema and the degree of exudation by down-regulating the inflammatory 
process. Honey dressings also reduce wound pain resulting from nerve endings being 
sensitized by prostaglandins produced during and from the pressure on tissues caused 
by oedema. The high sugar content of honey also prevents pain when dressings are 
changed due to the fact that it keeps the wound surface moist by mobilizing the 
oedema from the surrounding tissues. The remarkable debriding action of honey is 
also often observed and this is associated with the sloughing of bacteria-rich material 
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(Molan, 2002). Finally medical honey successfully prevents malodour from chronic 
colonized wounds which can cause severe discomfort and social isolation in patient.  
    Silver dressings are less useful than honey products because they can raise liver 
enzymes and cause an argyria-like syndrome in burns patients (Trop, 2006). As has 
been shown here, silver dressings often do not exhibit marked antibacterial activity. 
Iodine dressings have the disadvantage in having severe, harmful effects on the 
thyroid (Bradshaw, 2011). 
   For safety reasons, it is recommended that wound with medical honey dressings in 
all casesshould be supervised by a physician or an experienced wound care nurse in 
patients with chronic complicated wounds. Medical honey dressings also should keep 
the honey in contact with the wound for at least 12 h, but preferably for 24 h. Some 
patients apply the wound dressing overnight, so as not to restrict their mobility 
throughout the day. The frequency of dressing changes depends on the amount of 
exudates. In early stages, fresh surgical wounds infected with pathogenic bacteria may 
require changing twice daily. In stable wound care situations; dressings can be left in 
place for up to 7 days (Gethin, 2005, White, 2005). 
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7-1.Final Discussion 
Russian army medics used honey in World War I to prevent wound infection and to 
accelerate wound healing and in both World Wars, the Germans used a mixture of cod 
liver oil and honey to treat ulcers in surface infections (Bansal etal., 2005). Honeys 
have been applied with success to: abscesses, amputation wounds, bed sores, burns, 
chilblains, cracked nipples, fistulas, varicose wounds, septic and surgical. Honey 
application to a wound often leads to a stimulation in the rate of healing, essentially 
because honeys cleanse wounds and stimulate tissue regeneration as well as reducing 
inflammation. Dressings containing honey thereby provide a useful non adhesive 
tissue dressing (Efem, 1988). The molecular mechanism by which such wound 
healing using honey has not yet been determined. Honey both soothes and helps heal 
infected burns and it can potentially be used in the treatment of gingivitis and 
periodontal disease. Honey dressings speed healing, sterilizes wounds and reduces 
pain (Subrahmanyam, 1991). Honey is used with success to treat ulcerations resulting 
from radical surgery for breast cancer and following radical surgery for carcinoma of 
the vulva. Similar improvements are observed in following honey treatment of bed 
sores (Subrahmanyam, 1993). Perhaps, surprisingly, honey can also be used to treat 
eruptions in measles (Meda et al., 2004). Recent research has shown peripheral blood 
B-lymphocytes and T-lymphocytes proliferate markedly in cell cultures containing 
honeys; additionally, honey increases phagocyte activity (Olaitan et al., 2007). 
Finally, the rapid healing following the use of honey can be economically beneficial 
as it leads to a reduction in hospital and surgical costs (Zumla and Lulat, 1989). 
Honey can be given by mouth to treat and protect against gastrointestinal infection, 
including gastritis, duodenitis and bacterial and viral gastric ulceration (Tallett et al., 
1977) largely because honey blocks bacterial adherence to the stomach lining 
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(Alnaqdy et al., 2005). Diarrhoea and gastroenteritis also respond to honey (Bansal et 
al., 2005), and H. pylori is also sensitive to honey treatment (al Somal et al., 1994). 
Honey can also be used to treat fungal infections including dermatophytoses and  
candidiasis (Obaseiki-Ebor and Afonya, 1984) and cutaneous and superficial mycoses 
like ringworm and athletes foot; it is also effective against seborrheic dermatitis and 
dandruff (Al-Waili, 2001). Honey also treats recurrent lesions from labial and genital 
herpes and inhibits the rubella virus. Honey is also used to treat ophthalmological 
infections such as blepharitis, keratitis, conjunctivitis, corneal injuries, chemical and 
thermal burns to eyes(Shenoy et al., 2009). Honey also decreases venous blood 
pressure(Rakha et al., 2008). Honey is also anticarcinogenic (Bansal et al., 2005) and 
has antineoplastic activity in the experimental bladder cancer (Swellam et al., 2003). 
Finally, honey is relatively free of adverse effects, although topical application can 
lead to transient stinging sensation; despite this, honey usually relieves pain and is 
both non-irritating and provides a painless dressing change. Honey allergy is rare 
although there could be an allergic reaction to the presence of either pollen or bee 
proteins. Excessive application of honey may lead to tissue dehydration. Risk of 
wound botulism by Clostridia should be eliminated by gamma irradiation of honey 
without any loss of antibacterial activity (Bansal et al., 2005). 
  Patients suffering from suppressed immune system, due to diseases such as 
leukaemia and chemotherapy often suffer wound healing problems (Simon et al., 
2006, Gaur et al., 2005), as well as enhanced susceptibility to wound infections; 
infections which can cause secondary potentially life-threatening infections of the 
blood stream (Gaur et al., 2004). Such wounds can often be effectively treated with 
honey (Apitherapy). Honey works by being hygroscopic and drawing moisture out of 
the wound environment; it thus dehydrates bacteria. Much of this activity is due to its 
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sugar content, although his alone does not explain honey's antibacterial properties. 
Although hydrogen peroxide is a major component of honey, Manuka honey also 
contains other components with antibacterial qualities, notably methylglyoxal (MG); 
MG is a compound found in most types of honey, but generally in small quantities. 
Generally, the higher the concentration of MG, the stronger the antibiotic effect. In 
Manuka honey, MG comes from the conversion of dihydroxyacetone, a compound 
found in high concentrations in the nectar of Manuka flowers. Medical honey consists 
of standard mixture of different Manuka (Leptospermum spp are known by various 
common names in both Australia and New Zealand, including Tea Tree, Manuka, 
Goo Bush and Jelly Bush; it exhibits a standard antibacterial activity as confirmed by 
appropriate in vitro testing methods. The antibacterial properties 
from Leptospermum spp. honeys are both stable to light and heat and activity is not 
destroyed by sterilization with gamma-irradiation (Molan and Allen, 1996). Some 100 
candidates for the antibacterial property of Manuka honey have been suggested 
(Yaghoobi et al., 2013).Even though the active ingredient has yet identified to be 
methylglyoxal (MG) (Adams et al., 2009). Honey producers have developed a scale 
for rating the potency of Manuka honey called UMF, Unique Manuka Factor. The 
UMF rating corresponds with the concentration of MG. To be considered potent 
enough to be therapeutic use, Manuka honey needs a minimum rating of 10 UMF 
(Molan 1999). 
    Hydrogen peroxide activity is a major antibacterial component but if this is blocked 
and the osmotic effect of honey is also curtailed then Leptospermum spp. honeys still 
exhibit antibacterial activity. Non-Manuka honeys vary as much as 100-fold in their 
antibacterial activity, largely because the main factor involved is hydrogen peroxide 
(Lusby et al., 2005, Cooper et al., 1999, Cooper et al., 2002). 
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   In addition to being antibacterial, medical honey hastens the healing of wounds by 
virtue of its anti-inflammatory effects which help reduce oedema and the amount of 
wound exudates and pain which results from the nerve endings being sensitized by 
prostaglandins produced during inflammation, as well from the pressure on tissues 
resulting from oedema. The high sugar content of honey also reduces pain, when 
dressings are changed, as it keeps the wound surface moist by mobilizing the oedema 
from the surrounding tissues. Honey also stimulates the rate of angiogenesis, 
granulation and epithelialisation (Gupta et al., 1992), which helps explain the positive 
results of clinical trials which show that honey speeds up the healing process (Molan, 
2006). Honey may also work via its stimulation of an inflammatory response in 
leukocytes (Tonks et al., 2003), as inflammation triggers the cascade of cellular 
events that produce the growth factors controlling angiogenesis and the proliferation 
of both fibroblasts and epithelial cells.  
   Another mechanism may be related to the low pH level of honey (i.e. pH 3.4–5.5; 
mean 4.4), since it has been shown that acidification of wounds speeds healing (Rendl 
et al., 2001).This was attributed to the low pH increasing the amount of oxygen being 
off-loaded from capillary haemoglobin. It may also result from suppression of 
protease activity in wounds by moving the pH away from neutral, i.e. the optimum for 
their activity (Rushton, 2007).  
    Honey also shows a marked debriding action which helps to remove slough which 
is a rich source of bacteria to stimulate an inflammatory response (Molan, 2002). 
Finally, but very importantly, medical honey successfully reduces the problem of 
malodour from chronic suppurating wounds.  
    Honey must be sterilized before it is used on wounds, largely because it can suffer 
Clostridial contamination, as a result it should not be fed to infants. Such 
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contamination could lead to spores germinating in anaerobic environments within the 
wound leading to toxin production and associated paralysis and cardiac arrhythmia. In 
order to eliminate botulism spores, honey must be heated to 120°C for 10 min, a 
treatment, which causes adverse changes to the beneficial properties of honey. Since 
Clostridium spores may be found in Manuka honey, for medical purposes it is 
gamma irradiated, a process, which does not affect its antibacterial activity (Molan 
and Allen 1996). 
   Medical honey meets all the criteria expected of a successful wound curative, with 
the exception that they do not act particularly quickly. For example, medical honeys 
enhance and accelerate wound healing (debridement, granulation), even when applied 
for prolonged periods. They also produce no adverse local or systemic effects (e.g. 
allergy and toxicity problems related to absorption). Importantly, medical honeys are 
cheap to buy and use and need only be applied twice daily. 
   Medical honey is particularly effective in the treatment of recalcitrant wounds, 
notably indolent limb infections (Simon et al., 2006). The effectiveness of honey 
against antibiotic-resistant microorganisms suggests that it could be effectively used 
as an alternative means of chemoprophylaxis in patients with central venous catheters, 
and in the treatment of mucositis, a side effect of chemotherapy that attacks the entire 
gastrointestinal tract from the mouth to the anus and in the treatment of infants with 
polymicrobial infections (Vardi et al., 1998). Topical honey is safe and effective in 
the management of the signs and symptoms of recurrent lesions from labial and 
genital herpes (Al-Waili, 2004).According to this experience, children and adults are 
treated with recurrent herpetic lesions on the lips with medical honey, as soon as a 
new lesion is developing. In addition, topical medical honey is used in addition to 
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systemic acyclovir in immune compromized patients with zoster to prevent secondary 
bacterial skin infection and to accelerate healing of the herpetic lesions. 
    Medical honey dressings should keep the honey in contact with the wound for at 
least 12 h, but optimally for 24 h. They can be applied overnight, so as not to restrict. 
It is generally recommended that the best way to keep honey in a wound is to soak it 
into a calcium-alginate or hydro fiber dressing, which forms a gel with the honey as it 
absorbs the wound exudates; prepared medical honey products are available for this 
purpose. The frequency of dressing changes depends on the amount of exudates 
produced during treatment. In early stages, this may require a dressing to be change 
twice a day, although during stable wound care situations honey dressings have been 
left in place for up to 7 days (Gethin, 2004).  
   Results have shown a high patient acceptance for honey therapy. Amazingly wound 
dressings often have to be performed under general anaesthesia to alleviate pain and 
anxiety. However, shortly after the introduction of medical honey dressings, wounds 
often improve to such an extent that dressing changes can be performed without 
analgesic medication. If medical honey dressing is completely moistened with sterile 
Ringer solution, they can generally be readily and painlessly removed without any 
troublesome attachment to the wound. Another advantage of honey therapy is that 
care and ambulance workers, parents and relatives can be quickly educated in the 
aseptic application of honey dressings, which can be done at home or at work. 
   Honey can have the disadvantageous effect of causing stinging pain after 
administration, a problem that can be reduced by pre-treating the wound surface with 
a sterile anaesthetic cream. However, in some patients who experienced pain after 
administration, treatment with medical honey has to be stopped (Blaser et al., 2007b) 
or postponed to a later phase of wound healing. Despite this occasional adverse effect 
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honey treatment has been shown to be both low cost and highly effective 
(Subrahmanyam 1991, Johnson et al., 2005). 
The work presented in this Thesis shows that there are a number of potentially 
effective non-antibiotic honey based treatments which can be used to treat wound 
infections caused by antibiotic–resistant bacteria, work which provides motivation for 
studies on other alternative approaches to the control of wound infections. While 
considerable resources have been directed towards herbal medicine, less attention has 
been given to other diverse types of alternatives, examples of which include the use 
of: cod liver oil, chlorophyll, pectin, silicon and clays (Pugh, 1942). Cod liver oil was 
used in the Second World War to treat infected wounds, either by filling wound-
cavities, by using soaked dressings or by using a mixture of 30-50 % in Vaseline. Cod 
liver oil effectively kills bacteria when it is the oxidized, odorous state, suggesting 
that vitamin D may be the active ingredient. Highly ground silicon has also been used 
to treat wounds and can be given by mouth to cure for bleeding ulcers (Pugh, 1942).  
Stumpf (1906) used clay as a paste to treat indolent infections; it was found, not only 
to reduce infection, but also to lead to deodorization of the wound; it also stopped 
irritation and enhanced healing (Pugh, 1942). Kaolin clay has also been used to treat 
cholera in India and elsewhere and mortality rates can drop from 44% to near zero 
following its use (Nadkarni, 1906); kaolin combined with morphine was an old 
remedy used for stomach infections which could be found in the medical cabinets of 
most of UK households until the 1960s. All of the above named alternatives are 
clearly worthy of re-evaluation and after modern modification might be used in the 
future to treat antibiotic–resistant, indolent infections and maybe as in the case of 
clay-based remedies, for treating cholera. 
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    It may also be possible to combine antibiotics with other drugs in order to control 
antibiotic resistance. For example, Minocycline, an antibiotic that inhibits protein 
synthesis in bacteria (and to which bacteria developed resistance) has recently been 
re-evaluated for medical use when combined with other bioactive drugs. Sixty-nine 
compounds were, when added to this antibiotic, found to improve its effectiveness, 
allowing it again to be used as an antibacterial agent. Surprisingly, Imodium, the 
commonly used anti-diarrheal drug, also improved the antibacterial activity of 
Minocycline (Ejim et al., 2011). 
7 Finally, it is worth considering the commonly held ideas regarding the future, in 
regard to developments, which might solve the antibiotic resistance problem. Zucca 
and Savoia  (2010)suggest for example that this problem might be solved by the use 
of antimicrobial peptides, antivirulence factors, inhibitors of pathogen adhesion, 
inhibitors of pathogen colonization, inhibitors of toxin production and secretion, the 
development of antibodies, and finally phage therapy. Surprisingly, no mention is 
made of maggot or honey therapies, despite the fact that these approaches are 
currently being used in hospitals to treat antibiotic resistant infections. Clearly there 
exists a noticeable mismatch between the large amounts of research time which is 
devoted to theoretical applications of sophisticated approaches (e.g. gene therapy) and 
the current successful application of approaches such as apitherapy and maggot 
therapy. It would be obviously desirable to move away from these “primitive”, albeit 
successful approaches, especially since these cannot be used to treat systemic 
infections. Both intravenous maggot therapy is clearly impossible as presumably is 
the application of intravenous honey therapy (a German honey extract, referred to as 
M2 Woelem) was however, developed in the 1950s for use in gynaecology and 
obstetrics, (De Buman, 1953). 
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   In the absence of effective, more scientific approaches, historical approaches to 
wound treatment will continue to be used in practical medicine. There exist a range of 
other potential treatments, such as the use of chlorophyll and clays which have yet to 
be evaluated in modern Western medicine. While such alternatives to antibiotics can 
be seen as a desperate measure, and are only provisional, they may have to be used in 
practical medicine for some time yet until new antibiotics or other effective 
alternative approaches have been developed. 
 
 
 
Suggestions for Further Study 
1) New-Super honeys-Although the antibacterial effects of a variety of different 
honeys, from various parts of the work have been studied here (and in others Theses 
from this laboratory related to this topic),the potential still exists for a “super honey” 
to be discovered whose antibacterial properties will exceed those of Manuka honeys. 
Such honeys may prove to be particularly effective in killing bacteria when applied to 
wounds in dressings. Much in the way that novel antibiotic-producing organisms are 
sought, and screened for, from unusual habitats from all over the world so, one could 
imagine a similar search of honeys produced in remote areas of the world, which 
could prove successful as novel and highly effective antibacterial agents. It is 
recommended therefore that searches be made of remote areas in the hope of finding 
such as yet unknown active honeys. Obviously, care would need to be taken to avoid 
the possibility of importing into the UK viruses and other microbes which might 
destroy our native bee population. 
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2) Interactions between “failed antibiotics” and honey. It maybe that the use of 
antibiotics to which bacteria have developed resistance thereby making them of little 
use in medicine could be “revived” by mixing them with antibacterial honeys. This 
possibility is based on idea that the honey component would reduce the vitality of the 
bacterium, which would then be finally killed by the presence of the antibiotic 
component. Obviously such a combination would likely only be used on external 
wounds; although the author is not aware of any attempts to intravenously inject 
dilute honey solutions into human it can be assumed that these would cause 
anaphylactic shock or other adverse reactions.  
3) The need for clinical studies. This Thesis describes in vitro studies. It would 
obviously be highly desirable (and ultimately essential) to study the effects of the 
honeys used here on pathogenic bacteria and associated infections in vivo. This is 
obviously particularly important in relation to the effectiveness of the honey-
containing and other dressings studied here. The results of such studies may not be 
always directly related to microbiological effects. For example, it may be that these 
dressings are not useful because they cause excessive irritation and cannot be 
tolerated by some patients; such drawbacks would only be detected as the result of in 
vivo studies. Of course such studies obviously require the involvement of medical 
practitioners and patients, both of which we have no access to at present. 
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Appendix 1. Preparation of bacterial turbidity-standard suspensions 
        Sensitivity tests were adjusted to 1.5x106 colony forming units (CFU) which 
equals 0.5 McFarland. Briefly, two to three isolated colonies of the same 
morphological type were taken with a sterile loop and inoculated into a tube 
containing nine ml of nutrient broth and incubated in 37oC for 2 hrs. After incubation, 
the turbidity was measured in spectrophotometer at 650 nm and the measurement was 
recorded. The contents of the tube was diluted by taking 1 ml of the broth and 
transferred to another tube containing 9 ml sterile nutrient broth; this was the first 
dilution (10-1), the same step was then repeated five times to achieve the dilution of 
(10-5); 0.1 ml was taken from the last dilution and poured and spread on sterile 
nutrient agar plate. The plate was incubated for 24 hrs then the total colony count was 
counted and timed 105 and 10 was added to the total to get the actual concentration of 
106, i.e. the suspension density. If the colony number was too high then it was further 
diluted with nutrient broth and same steps then should be repeated to obtain 1-2 
colonies forming units in dilution 10-5.  
 
Appendix 2. Well diffusion technique 
Sterile Muller-Hinton agar (20 ml) plates were used. The surface of the plates was 
inoculated with previously calibrated inoculums of bacteria and allowed to dry before 
incubation in 37o C for 30 minutes. Five wells of 8.0 mm in diameter were cut from 
the culture media by using a sterile metal cylinder, and then filled with the previous 
mentioned concentrations. Vancomycin (30 µg) was used as a positive control for 
Staphylococcus aureus and Imipenem (10 µg) for Pseudomonas aeruginosa. The 
plates were incubated at 37oC and checked after 24 hrs for clear, circular inhibition 
zones around the wells. These zones were then measured. 
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Appendix 3. Identification of bacterial isolates using the 16s rRNA technique 
A bacterial suspension in nutrient broth was prepared and incubated overnight at 
370C. After the incubation period, 1-3 ml of media was transferred in a sterile 
Ependorf   tube and centrifuged at 6000 x g for 2 min at room temperature and the 
supernatant was decanted completely. A KeyPrep bacterial DNA extraction kit 
supplied by ANACHEM® was used and all steps were done as described in the 
instructions provided by the company. Buffer (RI, 100µl) was added to the pellet and 
the cells were resuspended completely by pipetting up and down. After full cell 
homogenising, 20 µl of lysosyme was added and mixed thoroughly and incubated at 
370C for 20 min. The mixture was then centrifuged at 10,000xg for 3 min and the 
supernatant was completely decanted. The pellet was resuspended in 180 µl of buffer 
R2 and 20 µl of proteinase K was added and incubated at 650C for 20 min in a water 
bath with occasional mixing every 5 min. 400 µl of buffer BG was added and mixed 
thoroughly by inverting the tube several times until a homogeneous solution was 
obtained and then incubated for 10 min at 650C. After the incubation period 200 µl of 
absolute ethanol was added and mixed thoroughly. The sample was transferred into a 
column which was assembled in a clean collection tube and centrifuged at 10,000xg 
for 1 min while the flow was discarded. The column was washed by addition of 750 
µl of wash buffer and centrifuged at 10,000xg for 1 min while the flow was discarded. 
Finally, the column was placed in a clean microcentrifuge tube and 70µl of elution 
buffer was added and centrifuged at 10,000xg for 2 min to elute DNA. DNA was 
stored at -200C until the next step. 
Gelelectrophoresis 
Gel electrophoresis was conducted to make sure that the bacterial DNA was well 
extracted and purified. The following steps were used: 
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 Agarose preparation 
Molecular biology grade agarose (0.5 g) was dissolved in 50 ml of 1x TAE (Tris 
Acetate EDTA) buffer and 40ml distilled water by heating in a microwave oven. The 
solution was mixed gently and allowed to cool to 550C, and 2.5 µl of ethidium 
bromide was added. After mixing, the solution was poured into a sealed gel rack and a 
comb was inserted at one side of the gel vertically and left at room temperature for 20 
min to solidify. Then the comb was removed and gel was placed into an 
electrophoresis tank and submerged in 1x TAE buffer.  
 Sample loading 
The DNA sample (10 µl) was mixed with 2 µl of Blue/Orange 6x loading dye with 
glycerine and loaded into the wells. 6 µl of 1 kb hyper ladder was added into an 
adjacent well as a reference. The settings were 40 minutes at 80V to allow the DNA 
to migrate toward the anode. Afterwards the DNA fragments were visualized under a 
UV transilluminator and the images were captured using a connected digital camera.    
 Sample amplification 
Samples were amplified using Polymerase Chain Reaction (PCR) technique. 
A mixture in a sterile Eppendorf tube was prepared as follows: 
Master mix, 12 µl, 1 µl of forward primer (5'-CCGAATTCGTCGACAACAGAGGATCCTGGCTCAG-3'), 
1 µl of reverse primer(5'- CCCGGGATCCAAGCTTACGGCTACCTTGTTACGACTT-3'), 1 µl of the DNA 
sample, and 35 µl of sterile distilled water. The mixture was then inserted in a PCR 
machine and the programme was adjusted as follows: 
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Serial Temperature Time(Min) Passes total 
1 940C 3 1 
2 940C 1 35 
3 600C 1 35 
4 720C 1 35 
5 720C 5 1 
6 40C ∞ 1 
 
16SrRNA sequencing and phylogenetic analysis 
After PCR, aliquots of 10 µl of each sample with 1µl of forward primer and 1µl of 
reverse primer in a sterile small size tube were sent to the Medical School Core 
Genetics Unit (University of Sheffield) to be sequenced. The 16S rRNA gene 
sequences were adapted using the Finch TV software and then exported into the Basic 
Local Alignment Search Tool (BLAST), available from the website of the National 
Centre for Biotechnology Information (NCBI), to identify matches with existing 
characterized reference sequences.  
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Appendix 4. Determination of minimum biofilm eradication concentration 
(MBEC): 
Inoculum preparation  
        More than 7 colonies of the same morphological appearance of a fresh subculture 
of the tested bacteria were picked off with a sterile loop and dipped into 1.5 ml sterile 
nutrient broth. 1 ml of prepared inocula transferred into 29 ml of nutrient broth. This 
30 fold dilution of the 1.0 McFarland standard serves as the inocula for the MBEC 
plate (Figure 34). A new MBEC plate was opened and the first row and the second 
row of pegs were removed by using sterile metal pliers to use these rows as negative 
controls afterward.  
22 ml of the previous prepared fold dilution was added to the MBEC plate and 
incubated in 37oC for 48 hrs in case of Staphylococcus aureus and 96 hrs in case of 
Pseudomonas aeruginosa (Wirtanen et al., 2001). 
 
 
Figure34. The MBEC plate (B) and biofilm formation on the peg (A) 
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Preparing the antimicrobial challenge plate 
Concentrations of the treatment were prepared previously in sterile tubes and then 
transferred to wells depending on the used treatment. The vertical well line was used 
for one type of honey from the third row to the eleventh row. The test for each type of 
honey was done in duplicate. The twelfth row used as positive control. 
Preparing a rinse plate 
        A sterile microtiter plate with 200 µl of physiological saline was setup in every 
well. This plate was used to rinse the pegs to remove loosely adherent planktonic cells 
from the biofilm.  
Exposure of biofilms 
        After the incubation period of the MBEC plate, the peg lid from the trough was 
removed and the pegs submersed in the wells of the rinse plate. The peg lid was let for 
1 to 2 minutes. This step was repeated in a new rinse plate.  
After washing, the peg lid of the MBEC was inserted into the challenge plate properly 
and incubated at 37oC for 24hrs. 
Neutralization and recovery 
        After the incubation period, the peg lid of the MBEC plate was washed twice 
using the same mentioned protocol in two different rinse plates. A 96 wells plate was 
prepared by adding 200 µl of nutrient broth in all wells and this was the recovery 
plate. The washed MBEC plate was transferred to the recovery plate and closed 
tightly to prevent any possibility of the contamination. The plate was transferred onto 
the tray of the sonicator.  The plate was left for 1 hour to allow the vibrations to 
disrupt the biofilms from the surface of the remaining pegs into the recovery plate. 
The plate was then incubated for 24 hrs and checked for the visible growth. 
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Appendix 5. Peroxide test 
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Appendix 6. Pseudomonas broth 
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Appendix Figures 
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Appendix Figure 1.The effect of different concentrations of Manuka +20 on S. aureus 
Biofilm 
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Appendix Figure 2.The effect of different concentrations of Manuka +20 on 
Pseudomonas aeruginosa Biofilm 
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Appendix Figure 3.The effect of different concentrations of New Zealand Rewarewa 
Honey on S. aureus biofilm 
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Appendix Figure 4.The effect of different concentrations of New Zealand Rewarewa 
Honey on Ps. aeruginosabiofilm 
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Appendix Figure 5. The effect of Nigella sativa honey with S. aureus biofilm 
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Appendix Figure 6.The effect of different concentrations of Nigella sativa honey on 
Ps. aeruginosabiofilm 
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Appendix Figure 7. The effect of different concentrations of oak honey on S. 
aureusbiofilm 
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Appendix Figure 8. The effect of different concentrations of Oak honey on Ps. 
aeruginosa biofilm 
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Appendix Figure 9.The effect of different concentrations of Erythromycin on            
S. aureus biofilm 
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Appendix Figure 10. The effect of different concentrations of Ciprofloxacin on       
Ps. aeruginosa biofilm 
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Appendix Figure 11. Pyocyanin standard curve 
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Appendix Figure 12. The effect of Manuka +20 honey on pyocyanin production 
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Appendix Figure 13. The effect of New Zealand Rewarewa honey on pyocyanin 
production 
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Appendix Figure 14. The effect of Nigella sativa honey on pyocyanin production 
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Appendix Figure 15. The effect of oak honey on pyocyanin production 
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Appendix Figure 16. The effect of Rain Forest +30 honey on pyocyanin production 
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Appendix Figure 17. The effect of Manuka +20 honey on the formation of the biofilm 
of S. aureus 
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Appendix Figure 18. The effect of New Zealand Rewarewa honey on the formation of 
the biofilm S. aureus 
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Appendix Figure 19. The effect of Nigella sativa honey on the formation of the 
biofilm of S. aureus 
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Appendix Figure 20. The effect of oak honey on the formation of the biofilm of S. 
aureus 
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Appendix Figure 21. The effect of Rain forest +30 honey on the formation of the 
biofilm of S. aureus 
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Appendix Figure 22. The effect of Manuka +20 honey on the formation of the biofilm 
of Ps. aeruginosa 
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Appendix Figure 23. The effect of New Zealand Rewarewa on the formation of the 
biofilm of Ps. aeruginosa 
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Appendix Figure 24. The effect of Nigella sativa on the formation of the biofilm of 
Ps. aeruginosa 
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Appendix Figure 25. The effect of oak honey on the formation of the biofilm of       
Ps. aeruginosa 
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Appendix Figure 26. The effect of Rain Forest +30 honey on the formation of the 
biofilm of Ps. aeruginosa 
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Appendix Figure 27.The activity of some dressings on the biofilm of S. aureus at 
different cases (NEB= Non Established Biofilm ) (EB24= Established Biofilm 
after 24 hrs) (EB48= Established Biofilm after 48 hrs) (* Significant 
differences) 
 
 
 
  * * * 
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Appendix Figure 28.  The activity of some dressings on the biofilm of Ps. aeruginosa 
at different cases (NEB= Non Established Biofilm) (EB24= Established 
Biofilm after 24 hrs) (EB48= Established Biofilm after 48 hrs) (* Significant 
differences) 
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Wound treatments
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                  = Positive Control  
  
Appendix figure 29.  The activity of some wound treatments on the biofilm of           
S. aureus (* Significant differences) 
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Wound treatments
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Appendix Figure 30. The activity of some wound treatments on the biofilm of         
Ps. aeruginosa (* Significant differences) 
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Appendix statistical analysis. 
Appendix statistical analysis 1. Raw and Autoclaved honey at 100% on S. aureus 
Data source: Data 3 in Raw Honey AND Autoclaved SA 100% 
Normality Test (Shapiro-Wilk) Failed (P < 0.050) 
Test execution ended by user request, Rank Sum Test begun 
Mann-Whitney Rank Sum Test  
Data source: Data 3 in Raw Honey AND Autoclaved SA 100% 
Group N  Missing  Median    25%      75%     
Col 5 5 0 19.333 19.167 22.500  
Col 6 5 0 15.667 15.500 15.833  
Mann-Whitney U Statistic= 0.000 
T = 40.000  n(small)= 5  n(big)= 5  P(est.)= 0.011  P(exact)= 0.008 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = 0.008) 
 
Appendix statistical analysis 2. The action of Raw Honey AND Autoclavedwith 
S. aureus at 80% 
Data source: Data 3 in Activity OF Raw Honey AND Autoclaved ON S. aureus AT 
80% 
Normality Test (Shapiro-Wilk) Failed (P < 0.050) 
Test execution ended by user request, Rank Sum Test begun 
Mann-Whitney Rank Sum Test Sunday, February 16, 2014, 15:08:00 
Data source: Data 3 in Activity OF Raw Honey AND Autoclaved ON S. aureus AT 
80% 
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Group N  Missing  Median    25%      75%     
Col 6 5 0 18.667 18.000 22.667  
Col 7 5 0 14.333 13.500 14.500  
Mann-Whitney U Statistic= 0.000 
T = 40.000  n(small)= 5  n(big)= 5  P(est.)= 0.012  P(exact)= 0.008 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = 0.008) 
 
Appendix statistical analysis 3. Raw and Autoclaved honey on Ps. aeruginosaat 
100% 
Data source: Data 3 in Activity OF Raw Honey AND Autoclaved on Ps. aeruginosa 
100% 
Normality Test (Shapiro-Wilk) Passed (P = 0.412) 
Equal Variance Test: Passed (P = 0.799) 
Group Name N  Missing Mean Std Dev SEM  
Col 1 5 0 13.333 1.900 0.850  
Col 2 5 0 11.400 2.216 0.991  
Difference 1.933 
t = 1.481  with 8 degrees of freedom. (P = 0.177) 
95 percent confidence interval for difference of means: -1.077 to 4.944 
The difference in the mean values of the two groups is not great enough to reject the 
possibility that the difference is due to random sampling variability. There is not a 
statistically significant difference between the input groups (P = 0.177). 
Power of performed test with alpha = 0.050: 0.154 
The power of the performed test (0.154) is below the desired power of 0.800. 
170!
!
Less than desired power indicates you are less likely to detect a difference when one 
actually exists. Negative results should be interpreted cautiously. 
 
Appendix statistical analysis 4. Raw and Autoclaved honey at 80% with 
Ps.aeruginosa 
Data source: Data 3 in Activity OF Raw Honey AND Autoclaved on Ps. 
aeruginosaat 80% 
Normality Test (Shapiro-Wilk) Passed (P = 0.984) 
Equal Variance Test: Passed (P = 0.465) 
Group Name N  Missing Mean Std Dev SEM  
Col 1 5 0 11.667 2.809 1.256  
Col 2 5 0 10.533 1.709 0.764  
Difference 1.133 
t = 0.771  with 8 degrees of freedom. (P = 0.463) 
95 percent confidence interval for difference of means: -2.258 to 4.524 
The difference in the mean values of the two groups is not great enough to reject the 
possibility that the difference is due to random sampling variability. There is not a 
statistically significant difference between the input groups (P = 0.463). 
Power of performed test with alpha = 0.050: 0.050 
The power of the performed test (0.050) is below the desired power of 0.800. 
Less than desired power indicates you are less likely to detect a difference when one 
actually exists. Negative results should be interpreted cautiously. 
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Appendix statistical analysis 5.Raw an Autoclaved Manuka +20 at 100% with S. 
aureus 
Data source: Data 4 in Activity OF Raw Honey AND Autoclaved on SA 100% 
Group Name N  Missing Mean Std Dev SEM  
Row 1 3 0 25.000 0.577 0.333  
Row 2 3 0 15.667 0.333 0.192  
Source of Variation  DF   SS   MS    F    P   
Between Groups1 130.667 130.667 588.000 <0.001  
Residual 4 0.889 0.222    
Total 5 131.556     
The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference  (P = 
<0.001). 
Power of performed test with alpha = 0.050: 1.000 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
ComparisonDiff of Means t P P<0.050   
Row 1 vs. Row 2 9.333 24.249 <0.001 Yes   
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Appendix statistical analysis 6. Raw and Autoclaved Manuka +20 honey on S. 
aureus at 80% 
Data source: Data 4 in Activity OF Raw Honey AND Autoclaved on S. aureus AT 
80% 
Group Name N  Missing Mean Std Dev SEM  
Row 1 3 0 24.667 1.202 0.694  
Row 2 3 0 13.667 0.882 0.509  
Source of Variation  DF   SS   MS          FP   
Between Groups1 181.500 181.500 163.350 <0.001  
Residual 4 4.444 1.111    
Total 5 185.944     
The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference  (P = 
<0.001). 
Power of performed test with alpha = 0.050: 1.000 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
ComparisonDiff of Means t P P<0.050   
Row 1 vs. Row 2 11.000 12.781 <0.001 Yes  
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Appendix statistical analysis 7. The activity of Raw and Autoclaved Rainforest 
+30 on Ps. aeruginosaat 100% 
Data source: Data 4 in Activity OF Raw Honey AND Autoclaved on Ps. 
aeruginosaAT 100% 
Group Name N  Missing Mean Std Dev SEM  
Row 1 3 0 15.667 0.333 0.192  
Row 2 3 0 10.667 0.333 0.192  
Source of Variation  DF   SS   MS    FP   
Between Groups1 37.500 37.500 337.500 <0.001  
Residual 4 0.444 0.111    
Total 5 37.944     
The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference  (P = 
<0.001). 
Power of performed test with alpha = 0.050: 1.000 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
ComparisonDiff of Means t P P<0.050   
Row 1 vs. Row2            5.000          18.371      <0.001       Yes   
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Appendix statistical analysis 8. Raw and Autoclaved Rainforest +30 honey on Ps. 
aeruginosaat 80% 
Data source: Data 4 in Activity OF Raw Honey AND Autoclaved on Ps. 
aeruginosaAT 80% 
Group Name N  Missing Mean Std Dev SEM  
Row 1 3 0 15.333 0.333 0.192  
Row 2 3 0 10.333 0.333 0.192  
Source of Variation  DF   SS   MS    FP   
Between Groups1 37.500 37.500 337.500 <0.001  
Residual 4 0.444 0.111    
Total 5 37.944     
The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference  (P = 
<0.001). 
Power of performed test with alpha = 0.050: 1.000 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
ComparisonDiff of Means t P P<0.050   
Row 1 vs. Row 2           5.000         18.371 <0.001    Yes   
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Appendix statistical analysis 9.The activity of some dressings on the planktonic 
of S. aureus 
One Way Analysis of Variance  
Data source: Data 2 in the activity of some dressings on S. aureus 
Group Name N  Missing Mean Std Dev SEM  
Row 1 3 0 18.000 0.000 0.000  
Row 2 3 0 31.667 3.786 2.186  
Row 3 3 0 25.333 1.155 0.667  
Row 4 3 0 19.000 1.000 0.577  
Source of Variation  DF   SS   MS    FP   
Between Groups 3 361.667 120.556 28.933 <0.001  
Residual 8 33.333 4.167    
Total 11 395.000     
The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference (P = 
<0.001). 
Power of performed test with alpha = 0.050: 1.000 
All Pair wise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
ComparisonDiff of Means t P P<0.050   
Row 2 vs. Row 1 13.667 8.200 <0.001 Yes   
Row 2 vs. Row 4 12.667 7.600 <0.001 Yes   
Row 3 vs. Row 1 7.333 4.400 0.009 Yes   
Row 2 vs. Row 3 6.333 3.800 0.016 Yes   
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Row 3 vs. Row 4 6.333 3.800 0.010 Yes   
Row 4 vs. Row 1 1.000 0.600 0.565 No   
 
Appendix statistical analysis 10.The effect of some dressings on the planktonic of 
Ps. aeruginosa 
One Way Analysis of Variance  
Data source: Data 2. The activity of some dressings on Ps. aeruginosa 
Group Name N  Missing Mean Std  Dev SEM  
Row 1     3 0 24.000 1.000 0.577  
Row 2 3 0 15.000 0.000 0.000  
Row 3 3 0 17.000 1.000 0.577  
Row 4 3 0 14.667 1.528 0.882  
 
Source of Variation  DF   SS   MS    FP   
Between Groups 3 170.000 56.667 52.308 <0.001  
Residual 8 8.667 1.083    
Total 11 178.667     
The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference (P = 
<0.001). 
Power of performed test with alpha = 0.050: 1.000 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
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ComparisonDiff of Means t P P<0.050   
Row 1 vs. Row 4 9.333 10.983 <0.001 Yes   
Row 1 vs. Row 2 9.000 10.590 <0.001 Yes   
Row 1 vs. Row 3 7.000 8.237 <0.001 Yes   
Row 3 vs. Row 4 2.333 2.746 0.074 No   
Row 3 vs. Row 2 2.000 2.353 0.091 No   
Row 2 vs. Row 4               0.333      0.392    0.705 No   
 
Appendix statistical analysis 11.Comparison between different wound 
treatments on the planktonic of S. aureus 
One Way Analysis of Variance  
Data source: Data 2. The activity of some wound treatments on S. aureus 
Group Name N  Missing Mean Std.Dev SEM  
Row 1 3 0 25.000 0.000 0.000  
Row 2 3 0 18.667 0.577 0.333  
Row 3 3 0 11.000 1.732 1.000  
Row 4 3 0 14.000 0.000 0.000  
Source of Variation  DF   SS   MS    FP   
Between Groups 3 335.000 111.667 134.000 <0.001  
Residual 8 6.667 0.833    
Total 11 341.667     
The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference (P = 
<0.001). 
Power of performed test with alpha = 0.050: 1.000 
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All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
ComparisonDiff of Means t P P<0.050   
Row 1 vs. Row 3 14.000 18.783 <0.001 Yes   
Row 1 vs. Row 4 11.000 14.758 <0.001 Yes   
Row 2 vs. Row 3 7.667 10.286 <0.001 Yes   
Row 1 vs. Row 2 6.333 8.497 <0.001 Yes   
Row 2 vs. Row 4 4.667 6.261 <0.001 Yes   
Row 4 vs. Row 3  3.000        4.025   0.004 Yes   
 
Appendix statistical analysis 12.The activity of some wound treatments on the 
planktonic of Ps.aeruginosa 
One Way Analysis of Variance  
Data source: Data 2 .The activity of some wound treatments onPs. aeruginosa 
Group Name N  Missing Mean Std.Dev SEM  
Row 1 3 0 25.333 0.577 0.333  
Row 2 3 0 12.333 0.577 0.333  
Row 3 3 0 13.667 1.528 0.882  
Row 4 3 0 16.667 1.155 0.667  
 
Source of Variation  DF   SS   MS    FP   
Between Groups 3 307.333 102.444 94.564 <0.001  
Residual 8 8.667 1.083    
Total 11 316.000     
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The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference (P = 
<0.001). 
Power of performed test with alpha = 0.050: 1.000 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
ComparisonDiff of Means t P P<0.050   
Row 1 vs. Row 2 13.000 15.297 <0.001 Yes   
Row 1 vs. Row 3 11.667 13.728 <0.001 Yes   
Row 1 vs. Row 4 8.667 10.198 <0.001 Yes   
Row 4 vs. Row 2 4.333 5.099 0.003 Yes   
Row 4 vs. Row 3 3.000 3.530 0.015 Yes   
Row 3 vs. Row 2             1.333       1.569        0.155        No   
 
Appendix statistical analysis 13.The comparison between different types of 
dressings on the ready biofilm for 24 hrs of S. aureus 
One Way Analysis of Variance  
Data source: Data 3 in Notebook1 
Group Name N  Missing Mean Std Dev SEM  
Row 1 3 0 4997626.667 323.316 186.667  
Row 2 3 0 4951000.000 20223.748 11676.187  
Row 3 3 0 4948333.333 9073.772 5238.745  
Source of Variation  DF   SS   MS    FP   
Between Groups2 4610989876.563 2305494938.281 14.074 0.005  
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Residual 6 982875731.151 163812621.858    
Total 8 5593865607.713     
The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference (P = 0.005). 
Power of performed test with alpha = 0.050: 0.946 
All Pair wise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
ComparisonDiff of Means t P P<0.050   
Row 1 vs. Row 3                 49293.333        4.717 0.010         Yes   
Row 1 vs. Row 246626.6674.462 0.009         Yes   
Row 2 vs. Row 3       2666.667        0.255      0.807         No   
 
Appendix statistical analysis 14.The comparison between different types of 
dressings on the ready biofilm for 48 hrs of S. aureus 
One Way Analysis of Variance  
Data source: Data 4 in Notebook1 
Group Name N  Missing Mean Std Dev SEM  
Row 1 3 0 4999296.667 300.389 173.429  
Row 2 3 0 4988166.667 4517.005 2607.894  
Row 3 3 0 4310000.000 65574.385 37859.389  
Source of Variation  DF   SS   MS    FP  
Between Groups2 935163799446.688 467581899723.344 324.673 <0.001  
Residual 6 8640987121.871 1440164520.312   
Total 8 943804786568.559    
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The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference (P = 
<0.001). 
Power of performed test with alpha = 0.050: 1.000 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
ComparisonDiff of Means t P P<0.050   
Row 1 vs. Row 3689296.667 22.246 <0.001 Yes   
Row 2 vs. Row 3678166.667 21.886 <0.001 Yes   
Row 1 vs. Row 211130.0000.359 0.732 No   
 
Appendix statistical analysis 15.Comparison between different types of dressings 
on non ready biofilm of Ps. aeruginosa 
One Way Analysis of Variance  
Data source: Data 3 in Ps. aeruginosabiofilm dressings 
Group Name N  Missing Mean Std Dev SEM  
Row 1 3 0 12.000 2.000 1.155  
Row 2 3 0 1995000.000 4618.802 2666.667  
Row 3 3 0 1999992.000 2.000 1.155  
Source of Variation  DF   SS   MS    F P  
Between Groups2 7.980E+012 3.990E+012561088.047 <0.001  
Residual 6 42666683.525 7111113.921    
Total 8 7.980E+012     
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The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference (P = 
<0.001). 
Power of performed test with alpha = 0.050: 1.000 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
ComparisonDiff of Means t P P<0.050   
Row 3 vs. Row1 1999980.000 918.549 <0.001 Yes   
Row 2 vs. Row1 1994988.000 916.257 <0.001 Yes   
Row 3 vs. Row2 4992.000 2.293 0.062No   
 
Appendix statistical analysis 16.Comparison between different types of dressings 
on  ready biofilm for 24 hrs  of Ps. aeruginosa 
One Way Analysis of Variance  
Data source: Data 4 in Ps. aeruginosa biofilm dressings 
Group Name N  Missing Mean Std Dev SEM  
Row 1 3 0 15.000 2.000 1.155  
Row 2 3 0 1975000.000 5000.000 2886.751  
Row 3 3 0 1999997.000 1.000 0.577  
 
Source of Variation  DF   SS   MS    FP   
Between Groups2 7.901E+012 3.951E+012474067.021 <0.001  
Residual 6 50000010.000 8333335.000    
Total 8 7.901E+012     
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The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference  (P = 
<0.001). 
Power of performed test with alpha = 0.050: 1.000 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
ComparisonDiff of Means t P P<0.050   
Row 3 vs. Row11999982.000848.520<0.001Yes   
Row 2 vs. Row11974985.000837.915<0.001 Yes   
Row 3 vs. Row224997.000 10.605 <0.001Yes   
 
Appendix statistical analysis 17.Comparison between different types of dressings 
on  ready biofilm for 48 hrs  of Ps. aeruginosa 
One Way Analysis of Variance  
Data source: Data 5 in Ps. aeruginosabiofilm dressings 
Group Name N  Missing Mean Std Dev SEM  
Row 1 3 0 11.000 2.000 1.155  
Row 2 3 0 1992000.000 2516.612 1452.966  
Row 3 3 0 1999991.000 1.500 0.866  
 
Source of Variation  DF   SS   MS    FP  
Between Groups2 7.968E+012 3.984E+0121887156.955 <0.001 
Residual 6 12666679.384 2111113.231    
Total 8 7.968E+012     
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The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference  (P = 
<0.001). 
Power of performed test with alpha = 0.050: 1.000 
 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
ComparisonDiff of Means t P P<0.050   
Row 3 vs. Row11999980.0001685.837<0.001 Yes   
Row 2 vs. Row11991989.0001679.101<0.001 Yes   
Row 3 vs. Row 2    7991.000         6.736 <0.001      Yes  
 
Appendix statistical analysis 18.Comparison between different wound 
treatments on the biofilm of S. aureus 
One Way Analysis of Variance  
Data source: Data 3 the effect of some wound treatments on the biofilm of S. aureus 
Group Name N  Missing Mean Std Dev SEM  
Row 1 3 0 0.125 0.128 0.0737  
Row 2 3 0 0.371 0.0943 0.0545  
Row 3 3 0 0.335 0.0118 0.00684  
Row 4 3 0 0.445 0.0690 0.0398  
Source of Variation  DF   SS   MS    F    P   
Between Groups 3 0.170 0.0566 7.523 0.010  
Residual 8 0.0602 0.00752    
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Total 11 0.230     
The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference (P = 0.010). 
Power of performed test with alpha = 0.050: 0.839 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
ComparisonDiff of Means t P P<0.050   
Row 4 vs. Row 1 0.320 4.524 0.012 Yes   
Row 2 vs. Row 1 0.246 3.474 0.041 Yes   
Row 3 vs. Row 1 0.211 2.975 0.069 No   
Row 4 vs. Row 3 0.110 1.549 0.407 No   
Row 4 vs. Row 2 0.0743 1.050 0.544 No   
Row 2 vs. Row 3 0.0353 0.499 0.631 No   
 
Appendix statistical analysis 19.Comparison between different wound 
treatments on the biofilm of Ps. aeruginosa 
One Way Analysis of Variance  
Data source: Data 2 in The effect of some wound treatments on the biofilm of 
Pseudomonas aeruginosa 
Group Name N  Missing Mean Std Dev SEM  
Row 1 3 0 1.005 0.00115 0.000667  
Row 2 3 0 0.333 0.0156 0.00902  
Row 3 3 0 0.353 0.247 0.143  
Row 4 3 0 0.000 0.0226 0.0131  
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Source of Variation  DF   SS   MS    F    P   
Between Groups 3 1.592 0.531 34.316 <0.001  
Residual 8 0.124 0.0155    
Total 11 1.716     
The differences in the mean values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference (P = 
<0.001). 
Power of performed test with alpha = 0.050: 1.000 
All Pairwise Multiple Comparison Procedures (Holm-Sidak method): 
Overall significance level = 0.05 
Comparisons for factor:  
ComparisonDiff of Means t P P<0.050   
Row 1 vs. Row 4 1.005 9.898 <0.001 Yes   
Row 1 vs. Row 2 0.672 6.619 <0.001 Yes   
Row 1 vs. Row 3 0.652 6.422 <0.001 Yes   
Row 3 vs. Row 4 0.353 3.477 0.025 Yes   
Row 2 vs. Row 4 0.333 3.280 0.022 Yes   
Row 3 vs. Row 2      0.0200        0.197    0.849    No  
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Appendix isolates. 16s rRNA gene sequences 
Appendix isolates 1.Isolate of Oak honey: 
 
Description 
Max  
Score 
Total 
Score 
Query 
coverage 
E 
Value 
Max ID 
Lysinibacillus fusiformis strain DD17 
16S ribosomal RNA gene, partial 
sequence 
649 649 100% 0 100% 
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Appendix isolates 2. Isolate from Nigella sativa honey 
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Appendix isolates 3. Isolate from Manuka honey 
 
Description 
Max 
Score 
Total 
Score 
Query 
coverage 
E 
Value 
Max 
ID 
Sporosarcina koreensis strain APT41 16S 
ribosomal RNA gene, partial sequence 
342 342 100% 5e-91 100% 
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Appendix isolates 4. Isolate T1 
 
 
 
 
 
 
 
 
 
Description 
Max  
score 
Total  
Score 
Query 
coverage 
E  
Value 
Max ID 
Streptococcus mitis strain NS51 16S 
ribosomal RNA, complete sequence. 
616 616 100% 1e-176 99% 
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Appendix isolates 5. Isolate T2 
 
Description 
Max 
Score 
Total 
Score 
Query 
coverage 
E 
Value 
Max 
ID 
Streptococcus gordonii str. Challis substr. CH1 
strain Challis 16S ribosomal RNA, complete 
sequence 
785 785 100% 0 100% 
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Appendix isolates 6.  Isolate T4 
 
Description 
Max 
Score 
Total 
Score 
Query 
coverage 
E 
Value 
Max 
ID 
Neisseria mucosa strain 5567a 16S 
ribosomal RNA gene, partial sequence 
941 941 100% 0 100% 
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